Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural molecule activity	KRT3 KRT5 COL12A1 ANK3 KRT86 PCLO SPTBN1 NUP214 POM121C MUC17 COL14A1 KRTAP24-1 POM121B MUC3A PRG4 MUC4 MUC5AC MUC6 EPB41 EPB41L1 OTOG MYBPC1	2.30e-09	891	109	22	GO:0005198
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A MUC4	6.30e-07	4	109	3	GO:0030197
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL12A1 MUC17 COL14A1 MUC3A PRG4 MUC4 MUC5AC MUC6	8.98e-06	188	109	8	GO:0005201
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	SI MGAM2	2.92e-04	5	109	2	GO:0004558
GeneOntologyMolecularFunction	structural constituent of nuclear pore	NUP214 POM121C POM121B	3.33e-04	25	109	3	GO:0017056
GeneOntologyMolecularFunction	nuclear localization sequence binding	NUP214 POM121C POM121B	4.21e-04	27	109	3	GO:0008139
GeneOntologyMolecularFunction	alpha-glucosidase activity	SI MGAM2	6.09e-04	7	109	2	GO:0090599
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	KRT5 ANK3 SPTBN1 EPB41 MYBPC1	7.36e-04	130	109	5	GO:0005200
GeneOntologyBiologicalProcess	neuron development	BOC KIF13B ANK3 HECW1 ZMYND8 NR4A3 MFRP WNK1 CSMD3 BMPR2 NRXN3 TIAM1 MEGF8 GORASP1 PTPRQ CD44 MAP3K13 RAPGEF2 CDH1 SDK1 ALK OTOG	8.01e-06	1463	110	22	GO:0048666
GeneOntologyBiologicalProcess	cell projection morphogenesis	BOC KIF13B ANK3 HECW1 NR4A3 BMPR2 NRXN3 TIAM1 MEGF8 GORASP1 CD44 MAP3K13 RAPGEF2 CDH1 MUC3A	3.27e-05	826	110	15	GO:0048858
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	BOC KIF13B ANK3 HECW1 NR4A3 BMPR2 NRXN3 TIAM1 MEGF8 GORASP1 PTPRQ MAP3K13 RAPGEF2 CDH1	4.42e-05	748	110	14	GO:0048667
GeneOntologyBiologicalProcess	neuron projection development	BOC KIF13B ANK3 HECW1 ZMYND8 NR4A3 CSMD3 BMPR2 NRXN3 TIAM1 MEGF8 GORASP1 CD44 MAP3K13 RAPGEF2 CDH1 SDK1 ALK OTOG	4.62e-05	1285	110	19	GO:0031175
GeneOntologyBiologicalProcess	cell morphogenesis	BOC KIF13B ANK3 HECW1 NR4A3 AP3B1 BMPR2 NRXN3 TIAM1 MEGF8 GORASP1 PTPRQ CD44 MAP3K13 RAPGEF2 CDH1 MUC3A EPB41	5.86e-05	1194	110	18	GO:0000902
GeneOntologyBiologicalProcess	modification of postsynaptic structure	FILIP1 STAU1 TIAM1 RAPGEF2	7.33e-05	42	110	4	GO:0099010
GeneOntologyBiologicalProcess	regulation of monocyte aggregation	NR4A3 CD44	8.43e-05	3	110	2	GO:1900623
GeneOntologyBiologicalProcess	positive regulation of monocyte aggregation	NR4A3 CD44	8.43e-05	3	110	2	GO:1900625
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	BOC KIF13B ANK3 HECW1 NR4A3 BMPR2 NRXN3 TIAM1 MEGF8 GORASP1 CD44 MAP3K13 RAPGEF2 CDH1	1.16e-04	819	110	14	GO:0120039
GeneOntologyBiologicalProcess	regulation of dendrite development	HECW1 CSMD3 TIAM1 GORASP1 RAPGEF2 ALK	1.54e-04	150	110	6	GO:0050773
GeneOntologyBiologicalProcess	modification of synaptic structure	FILIP1 STAU1 TIAM1 RAPGEF2	1.58e-04	51	110	4	GO:0099563
GeneOntologyBiologicalProcess	embryo development	COL12A1 GATAD2A MBNL1 POU2F1 NR4A3 KDM6B MFRP WNK1 YEATS2 BPTF BMPR2 MEGF8 LPA PTPRQ NFRKB SYVN1 CDH1 HCFC1 CDON	2.01e-04	1437	110	19	GO:0009790
GeneOntologyBiologicalProcess	positive regulation of dendritic cell apoptotic process	NR4A3 RAPGEF2	2.79e-04	5	110	2	GO:2000670
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC19 MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	1.57e-11	109	112	11	GO:0005796
GeneOntologyCellularComponent	spectrin-associated cytoskeleton	ANK3 SPTBN1 EPB41	1.23e-05	9	112	3	GO:0014731
GeneOntologyCellularComponent	extracellular matrix	COL12A1 MUC5B EYS MUC17 LPA COL14A1 PRG4 MUC4 MUC5AC MUC6 HCFC1 CDON OTOG	5.00e-05	656	112	13	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL12A1 MUC5B EYS MUC17 LPA COL14A1 PRG4 MUC4 MUC5AC MUC6 HCFC1 CDON OTOG	5.15e-05	658	112	13	GO:0030312
GeneOntologyCellularComponent	apical plasma membrane	SI MFRP MFSD4B HAVCR1 BMPR2 MUC17 PTPRQ CD44 RAPGEF2 MUC4 OTOG	6.19e-05	487	112	11	GO:0016324
GeneOntologyCellularComponent	apical part of cell	SI MFRP MFSD4B HAVCR1 BMPR2 MUC17 PTPRQ CD44 RAPGEF2 CDH1 MUC4 OTOG	8.00e-05	592	112	12	GO:0045177
GeneOntologyCellularComponent	anchoring collagen complex	COL12A1 COL14A1	8.51e-05	3	112	2	GO:0030934
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	MSL2 KANSL3 YEATS2 HCFC1	9.82e-05	45	112	4	GO:1902562
GeneOntologyCellularComponent	main axon	KIF13B ANK3 SPTBN1 TIAM1 CDH1	1.17e-04	89	112	5	GO:0044304
GeneOntologyCellularComponent	Hrd1p ubiquitin ligase complex	SYVN1 FAM8A1	1.70e-04	4	112	2	GO:0000836
GeneOntologyCellularComponent	ER ubiquitin ligase complex	SYVN1 FAM8A1	2.82e-04	5	112	2	GO:0000835
GeneOntologyCellularComponent	FACIT collagen trimer	COL12A1 COL14A1	4.21e-04	6	112	2	GO:0005593
GeneOntologyCellularComponent	microvillus	KIF13B MUC17 CD44 CDH1 MUC4	5.28e-04	123	112	5	GO:0005902
GeneOntologyCellularComponent	NSL complex	KANSL3 HCFC1	1.52e-03	11	112	2	GO:0044545
GeneOntologyCellularComponent	histone acetyltransferase complex	MSL2 KANSL3 YEATS2 HCFC1	1.64e-03	94	112	4	GO:0000123
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	GATAD2A SRCAP BPTF NFRKB	1.78e-03	96	112	4	GO:0070603
GeneOntologyCellularComponent	keratin filament	KRT3 KRT5 KRT86 KRTAP24-1	1.85e-03	97	112	4	GO:0045095
GeneOntologyCellularComponent	nuclear pore	RANBP2 NUP214 POM121C POM121B	2.14e-03	101	112	4	GO:0005643
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL12A1 EYS MUC17 LPA COL14A1 PRG4 MUC4 HCFC1 CDON	2.21e-03	530	112	9	GO:0062023
GeneOntologyCellularComponent	protein acetyltransferase complex	MSL2 KANSL3 YEATS2 HCFC1	2.38e-03	104	112	4	GO:0031248
GeneOntologyCellularComponent	cytoplasmic ubiquitin ligase complex	SYVN1 FAM8A1	2.48e-03	14	112	2	GO:0000153
GeneOntologyCellularComponent	A band	PPP1R12A SPTBN1 MYBPC1	2.73e-03	52	112	3	GO:0031672
GeneOntologyCellularComponent	acetyltransferase complex	MSL2 KANSL3 YEATS2 HCFC1	2.82e-03	109	112	4	GO:1902493
GeneOntologyCellularComponent	axon	BOC KIF13B ANK3 PCLO SPTBN1 AP3B1 CADM2 BMPR2 TIAM1 CDH1 ALK HCFC1	2.96e-03	891	112	12	GO:0030424
GeneOntologyCellularComponent	Set1C/COMPASS complex	HCFC2 HCFC1	3.25e-03	16	112	2	GO:0048188
GeneOntologyCellularComponent	paranode region of axon	KIF13B ANK3	3.67e-03	17	112	2	GO:0033270
GeneOntologyCellularComponent	actin-based cell projection	KIF13B MUC17 PTPRQ CD44 CDH1 MUC4	3.87e-03	278	112	6	GO:0098858
Domain	VWF_type-D	MUC19 MUC5B MUC4 MUC5AC MUC6 OTOG	2.35e-10	16	107	6	IPR001846
Domain	VWFD	MUC19 MUC5B MUC4 MUC5AC MUC6 OTOG	2.35e-10	16	107	6	PS51233
Domain	VWD	MUC19 MUC5B MUC4 MUC5AC MUC6 OTOG	2.35e-10	16	107	6	SM00216
Domain	VWD	MUC19 MUC5B MUC4 MUC5AC MUC6 OTOG	2.35e-10	16	107	6	PF00094
Domain	C8	MUC19 MUC5B MUC5AC MUC6 OTOG	4.31e-09	12	107	5	PF08742
Domain	TIL	MUC19 MUC5B MUC5AC MUC6 OTOG	4.31e-09	12	107	5	PF01826
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B MUC5AC MUC6 OTOG	6.97e-09	13	107	5	IPR014853
Domain	C8	MUC19 MUC5B MUC5AC MUC6 OTOG	6.97e-09	13	107	5	SM00832
Domain	TIL_dom	MUC19 MUC5B MUC5AC MUC6 OTOG	1.08e-08	14	107	5	IPR002919
Domain	VWC_out	MUC19 MUC5B MUC5AC MUC6 OTOG	6.13e-08	19	107	5	SM00215
Domain	CT	MUC19 MUC5B MUC5AC MUC6 OTOG	1.37e-07	22	107	5	SM00041
Domain	SEA	MUC3B MUC16 MUC12 MUC17 MUC3A	1.74e-07	23	107	5	PS50024
Domain	SEA_dom	MUC3B MUC16 MUC12 MUC17 MUC3A	1.74e-07	23	107	5	IPR000082
Domain	Cys_knot_C	MUC19 MUC5B MUC5AC MUC6 OTOG	2.72e-07	25	107	5	IPR006207
Domain	CTCK_2	MUC19 MUC5B MUC5AC MUC6 OTOG	2.72e-07	25	107	5	PS01225
Domain	SEA	MUC3B MUC16 MUC17 MUC3A	9.75e-07	14	107	4	SM00200
Domain	VWF_dom	MUC19 MUC5B MUC5AC MUC6 OTOG	4.04e-06	42	107	5	IPR001007
Domain	SEA	MUC3B MUC16 MUC12 MUC17	6.88e-06	22	107	4	PF01390
Domain	FN3	BOC COL12A1 COL14A1 HCFC2 SDK1 HCFC1 CDON MYBPC1	1.13e-05	185	107	8	SM00060
Domain	FN3	BOC COL12A1 COL14A1 HCFC2 SDK1 HCFC1 CDON MYBPC1	1.91e-05	199	107	8	PS50853
Domain	FN3_dom	BOC COL12A1 COL14A1 HCFC2 SDK1 HCFC1 CDON MYBPC1	2.72e-05	209	107	8	IPR003961
Domain	fn3	BOC COL12A1 COL14A1 HCFC2 SDK1 CDON MYBPC1	4.09e-05	162	107	7	PF00041
Domain	EGF_3	MUC3B EYS NRXN3 MEGF8 MUC17 MUC3A MUC4 OTOG	6.23e-05	235	107	8	PS50026
Domain	EGF-like_dom	MUC3B EYS NRXN3 MEGF8 MUC17 MUC3A MUC4 OTOG	9.33e-05	249	107	8	IPR000742
Domain	-	BOC COL12A1 CCDC141 CADM2 MFAP3L HAVCR1 CRTAM COL14A1 HCFC2 SDK1 HCFC1 CDON MYBPC1	1.07e-04	663	107	13	2.60.40.10
Domain	EGF_1	MUC3B MUC12 EYS NRXN3 MEGF8 MUC17 MUC3A MUC4	1.10e-04	255	107	8	PS00022
Domain	EGF-like_CS	MUC3B MUC12 EYS NRXN3 MEGF8 MUC17 MUC3A MUC4	1.29e-04	261	107	8	IPR013032
Domain	CTCK_1	MUC19 MUC5B MUC5AC	1.40e-04	18	107	3	PS01185
Domain	EGF_2	MUC3B MUC12 EYS NRXN3 MEGF8 MUC17 MUC3A MUC4	1.43e-04	265	107	8	PS01186
Domain	4_1_CTD	EPB41 EPB41L1	1.94e-04	4	107	2	PF05902
Domain	Gal_mutarotase_N	SI MGAM2	1.94e-04	4	107	2	IPR031727
Domain	LAMP_3	LAMP3 CD68	1.94e-04	4	107	2	PS51407
Domain	SAB	EPB41 EPB41L1	1.94e-04	4	107	2	PF04382
Domain	Band_4.1_C	EPB41 EPB41L1	1.94e-04	4	107	2	IPR008379
Domain	SAB_dom	EPB41 EPB41L1	1.94e-04	4	107	2	IPR007477
Domain	NtCtMGAM_N	SI MGAM2	1.94e-04	4	107	2	PF16863
Domain	Ig-like_fold	BOC COL12A1 CCDC141 CADM2 MFAP3L HAVCR1 CRTAM COL14A1 HCFC2 SDK1 HCFC1 CDON MYBPC1	1.98e-04	706	107	13	IPR013783
Domain	Lamp	LAMP3 CD68	3.22e-04	5	107	2	PF01299
Domain	Lysosome-assoc_membr_glycop	LAMP3 CD68	3.22e-04	5	107	2	IPR002000
Domain	Keratin_2_head	KRT3 KRT5 KRT86	3.39e-04	24	107	3	IPR032444
Domain	Keratin_2_head	KRT3 KRT5 KRT86	3.39e-04	24	107	3	PF16208
Domain	Laminin_G	COL12A1 EYS NRXN3 COL14A1	3.41e-04	58	107	4	IPR001791
Domain	EGF	MUC3B EYS NRXN3 MEGF8 MUC17 MUC3A MUC4	4.10e-04	235	107	7	SM00181
Domain	Keratin_II	KRT3 KRT5 KRT86	4.32e-04	26	107	3	IPR003054
Domain	Glyco_hydro_31_AS	SI MGAM2	4.80e-04	6	107	2	IPR030458
Domain	WxxW_domain	MUC5B MUC5AC	4.80e-04	6	107	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	4.80e-04	6	107	2	PF13330
Domain	Glyco_hydro_31	SI MGAM2	6.70e-04	7	107	2	IPR000322
Domain	Glyco_hydro_31	SI MGAM2	6.70e-04	7	107	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	SI MGAM2	6.70e-04	7	107	2	PS00129
Domain	Ig_I-set	BOC CADM2 MFAP3L SDK1 CDON MYBPC1	7.91e-04	190	107	6	IPR013098
Domain	I-set	BOC CADM2 MFAP3L SDK1 CDON MYBPC1	7.91e-04	190	107	6	PF07679
Domain	Trefoil	SI MGAM2	8.90e-04	8	107	2	PF00088
Domain	P_TREFOIL_2	SI MGAM2	1.14e-03	9	107	2	PS51448
Domain	PD	SI MGAM2	1.14e-03	9	107	2	SM00018
Domain	VWFC_2	MUC19 MUC5B MUC5AC	1.33e-03	38	107	3	PS50184
Domain	VWC	MUC19 MUC5B MUC5AC	1.33e-03	38	107	3	SM00214
Domain	ConA-like_dom	COL12A1 ADGRG4 EYS NRXN3 COL14A1 ALK	1.64e-03	219	107	6	IPR013320
Domain	-	SI MGAM2	1.73e-03	11	107	2	4.10.110.10
Domain	IG_LIKE	BOC CCDC141 CADM2 MFAP3L HAVCR1 CRTAM SDK1 CDON MYBPC1	2.05e-03	491	107	9	PS50835
Domain	P_trefoil_dom	SI MGAM2	2.07e-03	12	107	2	IPR000519
Domain	-	COL12A1 ADGRG4 EYS NRXN3	2.17e-03	95	107	4	2.60.120.200
Domain	IGc2	BOC CADM2 MFAP3L SDK1 CDON MYBPC1	2.34e-03	235	107	6	SM00408
Domain	Ig_sub2	BOC CADM2 MFAP3L SDK1 CDON MYBPC1	2.34e-03	235	107	6	IPR003598
Domain	Ig-like_dom	BOC CCDC141 CADM2 MFAP3L HAVCR1 CRTAM SDK1 CDON MYBPC1	2.41e-03	503	107	9	IPR007110
Domain	Kelch_2	HCFC2 HCFC1	2.43e-03	13	107	2	IPR011498
Domain	Kelch_2	HCFC2 HCFC1	2.43e-03	13	107	2	PF07646
Domain	FA	EPB41 EPB41L1	2.43e-03	13	107	2	PF08736
Domain	FERM-adjacent	EPB41 EPB41L1	2.43e-03	13	107	2	IPR014847
Domain	FA	EPB41 EPB41L1	2.43e-03	13	107	2	SM01195
Domain	-	MEGF8 HCFC2 HCFC1	2.62e-03	48	107	3	2.120.10.80
Domain	CUB	MFRP CSMD3 MEGF8	2.78e-03	49	107	3	PF00431
Domain	Neurexin-like	CADM2 NRXN3	2.83e-03	14	107	2	IPR003585
Domain	4.1m	CADM2 NRXN3	2.83e-03	14	107	2	SM00294
Domain	IG	BOC CADM2 MFAP3L HAVCR1 CRTAM SDK1 CDON MYBPC1	2.91e-03	421	107	8	SM00409
Domain	Ig_sub	BOC CADM2 MFAP3L HAVCR1 CRTAM SDK1 CDON MYBPC1	2.91e-03	421	107	8	IPR003599
Domain	CUB	MFRP CSMD3 MEGF8	2.95e-03	50	107	3	SM00042
Domain	-	MUC16 MUC17	3.25e-03	15	107	2	3.30.70.960
Domain	Glyco_hormone_CN	MUC5B MUC5AC	3.25e-03	15	107	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	3.25e-03	15	107	2	PF00007
Domain	-	MFRP CSMD3 MEGF8	3.30e-03	52	107	3	2.60.120.290
Domain	CUB	MFRP CSMD3 MEGF8	3.48e-03	53	107	3	PS01180
Domain	Kelch-typ_b-propeller	MEGF8 HCFC2 HCFC1	3.86e-03	55	107	3	IPR015915
Domain	Gal_mutarotase_SF_dom	SI MGAM2	4.18e-03	17	107	2	IPR011013
Domain	CUB_dom	MFRP CSMD3 MEGF8	4.27e-03	57	107	3	IPR000859
Domain	Gal_Oxase/kelch_b-propeller	MEGF8 HCFC2 HCFC1	4.71e-03	59	107	3	IPR011043
Domain	Intermediate_filament_CS	KRT3 KRT5 KRT86	5.66e-03	63	107	3	IPR018039
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	2.14e-16	16	95	9	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	4.52e-16	17	95	9	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	1.47e-14	23	95	9	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	5.53e-14	26	95	9	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC17 MUC4 MUC5AC MUC6	5.43e-11	21	95	7	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	2.95e-10	62	95	9	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	6.92e-10	68	95	9	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	5.60e-08	111	95	9	M27416
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC5B MUC17 MUC4 MUC5AC MUC6	1.46e-07	60	95	7	MM15636
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	4.14e-07	140	95	9	M27484
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	4.95e-07	143	95	9	M27275
Pathway	BIOCARTA_PDZS_PATHWAY	PCLO SPTBN1 NRXN3 EPB41	5.51e-06	18	95	4	M22001
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC16 SI MUC5B MUC12 MUCL1 MUC17 MUC3A MUC4 MUC5AC MUC6	6.93e-06	250	95	10	M27554
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC19 MUC16 MUC5B MUC17 MUC4 MUC5AC MUC6	8.60e-06	109	95	7	MM15164
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	RANBP2 NUP214 POM121C NEK9 POM121B	3.33e-05	55	95	5	MM14917
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	RANBP2 NUP214 POM121C NEK9	9.66e-05	36	95	4	M27245
Pathway	REACTOME_MITOTIC_PROPHASE	RANBP2 NUP214 POM121C NEK9 GORASP1 POM121B	1.19e-04	114	95	6	MM15361
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KANSL3 YEATS2 HCFC2 HCFC1	1.20e-04	38	95	4	MM17073
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	RANBP2 NUP214 POM121C POM121B	1.47e-04	40	95	4	MM14945
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	RANBP2 NUP214 POM121C POM121B	1.62e-04	41	95	4	MM15200
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KANSL3 YEATS2 HCFC2 HCFC1	1.78e-04	42	95	4	M48018
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	RANBP2 NUP214 POM121C POM121B	1.78e-04	42	95	4	MM15039
Pathway	WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS	ANK3 CSN3 EPB41 EPB41L1	1.78e-04	42	95	4	M39703
Pathway	WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS	ANK3 CSN3 EPB41 EPB41L1	1.78e-04	42	95	4	MM15822
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	RANBP2 NUP214 POM121C POM121B	1.95e-04	43	95	4	MM14609
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	RANBP2 NUP214 POM121C POM121B	2.77e-04	47	95	4	MM14939
Pathway	REACTOME_GENE_SILENCING_BY_RNA	RANBP2 NUP214 POM121C POM121B	3.25e-04	49	95	4	MM14837
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	RANBP2 NUP214 POM121C POM121B	3.52e-04	50	95	4	MM14610
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	RANBP2 NUP214 POM121C POM121B	3.80e-04	51	95	4	MM15151
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	RANBP2 NUP214 POM121C NEK9	4.40e-04	53	95	4	M27212
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	RANBP2 NUP214 POM121C POM121B	6.22e-04	58	95	4	MM15149
Pathway	REACTOME_SNRNP_ASSEMBLY	RANBP2 NUP214 POM121C POM121B	6.22e-04	58	95	4	MM14736
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	RANBP2 NUP214 POM121C POM121B	9.57e-04	65	95	4	MM15147
Pathway	REACTOME_LIGAND_RECEPTOR_INTERACTIONS	BOC CDON	1.23e-03	8	95	2	M27496
Pathway	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	RANBP2 NUP214 POM121C	1.28e-03	32	95	3	M29579
Pathway	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	RANBP2 NUP214 POM121C	1.40e-03	33	95	3	M27016
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	RANBP2 NUP214 POM121C POM121B	1.48e-03	73	95	4	MM14948
Pathway	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	RANBP2 NUP214 POM121C	1.52e-03	34	95	3	M27041
Pathway	KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR	BOC CDON	1.57e-03	9	95	2	M47893
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	RANBP2 NUP214 POM121C	1.66e-03	35	95	3	M27320
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	RANBP2 ANK3 SPTBN1 MUC16 MUC5B NUP214 MUC12 POM121C MUCL1 MUC17 TTLL6 GORASP1 NFRKB SYVN1 MUC3A MUC4 MUC5AC MUC6 HCFC1 FOXK1	1.71e-03	1475	95	20	M19806
Pathway	REACTOME_SENSORY_PROCESSING_OF_SOUND	PCLO SPTBN1 EPB41L1 OTOG	1.80e-03	77	95	4	M41822
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	RANBP2 NUP214 POM121C	1.80e-03	36	95	3	M26974
Pathway	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	RANBP2 NUP214 POM121C	1.95e-03	37	95	3	M1029
Pathway	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	RANBP2 NUP214 POM121C	1.95e-03	37	95	3	M27038
Pathway	REACTOME_GLUCOSE_METABOLISM	RANBP2 NUP214 POM121C POM121B	2.27e-03	82	95	4	MM15394
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	RANBP2 NUP214 POM121C	2.27e-03	39	95	3	M27238
Pathway	BIOCARTA_NPC_PATHWAY	RANBP2 NUP214	2.38e-03	11	95	2	M22033
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	RANBP2 NUP214 POM121C POM121B	2.47e-03	84	95	4	MM14929
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	RANBP2 NUP214 POM121C	2.63e-03	41	95	3	M29574
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	RANBP2 NUP214 POM121C POM121B	2.70e-03	86	95	4	MM15413
Pathway	REACTOME_MITOTIC_PROPHASE	RANBP2 NUP214 POM121C NEK9 GORASP1	2.71e-03	142	95	5	M27660
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	RANBP2 NUP214 POM121C	3.01e-03	43	95	3	M26975
Pathway	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	RANBP2 NUP214 POM121C	3.21e-03	44	95	3	M109
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	RANBP2 NUP214 POM121C POM121B	3.44e-03	92	95	4	MM14951
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	MSL2 KANSL3 HCFC1	3.65e-03	46	95	3	MM14935
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	RANBP2 NUP214 POM121C	3.65e-03	46	95	3	M27397
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	RANBP2 NUP214 POM121C	3.88e-03	47	95	3	M27395
Pathway	REACTOME_CELL_CELL_COMMUNICATION	KRT5 SPTBN1 CADM2 CDH1 SDK1	3.95e-03	155	95	5	M522
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC17 MUC3A MUC4 MUC5AC MUC6	1.38e-18	18	113	9	18834073
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B MUC5AC MUC6	1.98e-12	6	113	5	19110483
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 RANBP2 ATN1 SFSWAP SPTBN1 ZMYND8 POU2F1 NUP214 HUWE1 KANSL3 YEATS2 BPTF NFRKB SPEN PRG4 DCP1A SON	5.85e-10	774	113	17	15302935
Pubmed	Human transcription factor protein interaction networks.	KLF12 ATN1 GATAD2A SPTBN1 MBNL1 ZMYND8 POU2F1 NUP214 SRCAP POM121C STAU1 KANSL3 YEATS2 BPTF ZNF608 TCERG1 NFRKB HCFC2 SPEN HCFC1 FOXK1 DCP1A	1.11e-09	1429	113	22	35140242
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	KLF12 AFF2 ATN1 ANK3 ZMYND8 NUP214 POM121C WNK1 CCDC141 NEK9 C6orf132 SPEN SON	1.65e-09	430	113	13	35044719
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ANK3 PPP1R12A HUWE1 SRCAP AP3B1 NEK9 YEATS2 BPTF TCERG1 NFRKB SPEN HCFC1 EPB41 DCP1A	3.32e-09	549	113	14	38280479
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B PPP1R12A SPTBN1 WNK1 NEK9 C6orf132 BMPR2 TIAM1 MEGF8 TCERG1 RAPGEF2 FOXK1 EPB41 EPB41L1 DCP1A OTOG	2.05e-08	861	113	16	36931259
Pubmed	Interaction network of human early embryonic transcription factors.	RANBP2 ATN1 POU2F1 NUP214 POM121C BPTF ZNF608 NFRKB SPEN CDH1 FOXK1	2.20e-08	351	113	11	38297188
Pubmed	Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos.	ANK3 SPTBN1 CDH1	3.34e-08	3	113	3	17620337
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A MUC5AC	3.34e-08	3	113	3	18163520
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	3.34e-08	3	113	3	10512748
Pubmed	Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis.	SPTBN1 CD44 EPB41	3.34e-08	3	113	3	12901833
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	HECW1 HUWE1 KDM6B SRCAP WNK1 RAPGEF2 EPB41L1	5.19e-08	104	113	7	9205841
Pubmed	A human MAP kinase interactome.	KRT5 RANBP2 ANK3 SPTBN1 NUP214 MUC12 POM121C WNK1 MSL2 TCERG1 RAPGEF2 ABLIM2	6.68e-08	486	113	12	20936779
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RANBP2 GATAD2A SFSWAP MBNL1 ZMYND8 NUP214 STAU1 YEATS2 BPTF TCERG1 NFRKB SPEN ALK HCFC1 EPB41 SON	8.38e-08	954	113	16	36373674
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ATN1 GATAD2A SFSWAP PPP1R12A ZMYND8 KIAA1549 SRCAP POM121C YEATS2 BPTF ZNF608 NFRKB CEP295 TAF4B RAPGEF2 FOXK1 SON	1.25e-07	1116	113	17	31753913
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	1.33e-07	4	113	3	23807779
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	1.33e-07	4	113	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	1.33e-07	4	113	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	1.33e-07	4	113	3	29869461
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	1.33e-07	4	113	3	12676567
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	RANBP2 NUP214 POM121C POM121B	1.40e-07	15	113	4	14697343
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	RANBP2 ZMYND8 MUC19 NUP214 POM121C YEATS2 HCFC1	1.65e-07	123	113	7	26912792
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RANBP2 GATAD2A SFSWAP ZMYND8 NUP214 SRCAP POM121C MSL2 KANSL3 YEATS2 BPTF TCERG1 NFRKB HCFC2 SPEN HCFC1 FOXK1 SON	1.97e-07	1294	113	18	30804502
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	RANBP2 GATAD2A STAU1 KANSL3 YEATS2 ZNF608 TCERG1 NFRKB HCFC1 FOXK1 DCP1A	2.35e-07	444	113	11	34795231
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KRT5 AFF2 ANK3 SFSWAP MUC16 HUWE1 AP3B1 CD44 HCFC2 RAPGEF2 SPEN SDK1 EPB41 CDON	2.45e-07	777	113	14	35844135
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ZMYND8 KANSL3 YEATS2 TCERG1 NFRKB SPEN HCFC1	2.96e-07	134	113	7	25452129
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC4 MUC5AC	3.32e-07	5	113	3	11062147
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC4 MUC5AC MUC6	3.32e-07	5	113	3	16475027
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RANBP2 PPP1R12A ZMYND8 NUP214 SRCAP POM121C WNK1 NEK9 STAU1 YEATS2 TCERG1 HCFC1 EPB41 DCP1A SON	3.82e-07	934	113	15	33916271
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PCLO MBNL1 ZMYND8 HUWE1 TMEM131 RAPGEF2	4.19e-07	87	113	6	12465718
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KIF13B KLF12 ANK3 PPP1R12A SPTBN1 MBNL1 HUWE1 SRCAP AP3B1 WNK1 HAVCR1 NFRKB TMEM131 CEP295 CDH1 DCP1A	4.64e-07	1084	113	16	11544199
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	RANBP2 GATAD2A SFSWAP SPTBN1 ZMYND8 HUWE1 MSL2 TCERG1 HCFC1 FOXK1 EPB41 SON	4.67e-07	583	113	12	29844126
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	BOC RANBP2 COL12A1 SPTBN1 WNK1 CCDC141 NEK9 COL14A1 ABLIM2 SON MYBPC1	7.13e-07	497	113	11	23414517
Pubmed	FGFR2 is essential for salivary gland duct homeostasis and MAPK-dependent seromucous acinar cell differentiation.	KRT5 MUC19 MUCL1 CDH1	7.39e-07	22	113	4	37838739
Pubmed	E-cadherin is required for intestinal morphogenesis in the mouse.	MUC17 CD44 CDH1 MUC4	1.07e-06	24	113	4	22766025
Pubmed	Diverse progenitor cells preserve salivary gland ductal architecture after radiation-induced damage.	KRT5 MUC19 CDH1	1.16e-06	7	113	3	30305288
Pubmed	Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.	HUWE1 NEK9 TCERG1 HCFC1 EPB41	1.21e-06	57	113	5	38223760
Pubmed	Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.	CD44 CDH1 MUC5AC MUC6	1.27e-06	25	113	4	34391772
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	KIAA0586 MUC16 MUC5B HUWE1 TIAM1 SDK1 OTOG	1.47e-06	170	113	7	23314748
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	RANBP2 SPTBN1 ZMYND8 NUP214 HUWE1 SRCAP BPTF TCERG1 HCFC1	1.48e-06	332	113	9	32786267
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	FILIP1 RANBP2 HECW1 NUP214 BPTF TIAM1 TCERG1 SON	1.70e-06	250	113	8	33536335
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	KIF13B ZMYND8 SRCAP POM121C BPTF SPEN HCFC1 FOXK1 DCP1A	1.84e-06	341	113	9	32971831
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RANBP2 ANK3 KIAA1549 CPD POM121C C6orf132 TCERG1 TMEM131	2.48e-06	263	113	8	34702444
Pubmed	The hedgehog co-receptor BOC differentially regulates SHH signaling during craniofacial development.	BOC CDH1 CDON	2.77e-06	9	113	3	33060130
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	RANBP2 HUWE1 WNK1 NEK9 TCERG1 NFRKB HCFC1 FOXK1	2.77e-06	267	113	8	33417871
Pubmed	Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling.	BOC CD44 CDH1 CDON	3.11e-06	31	113	4	36971701
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	KRT3 GATAD2A PPP1R12A ZMYND8 KANSL3 YEATS2 BPTF CD44 EPB41 DCP1A	3.44e-06	472	113	10	38943005
Pubmed	GemC1 controls multiciliogenesis in the airway epithelium.	KRT5 CDH1 MUC5AC	3.94e-06	10	113	3	26882546
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RANBP2 GATAD2A PPP1R12A ZMYND8 POU2F1 HUWE1 KANSL3 BPTF TCERG1 SPEN HCFC1 FOXK1 DCP1A	4.49e-06	857	113	13	25609649
Pubmed	CDON contributes to Hedgehog-dependent patterning and growth of the developing limb.	BOC CDH1 CDON	5.41e-06	11	113	3	36265686
Pubmed	GATA4 Controls Epithelial Morphogenesis in the Developing Stomach to Promote Establishment of Glandular Columnar Epithelium.	KRT5 CDH1 MUC5AC	5.41e-06	11	113	3	34111600
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	RANBP2 NUP214 POM121C POM121B	7.16e-06	38	113	4	12791264
Pubmed	Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex.	MSL2 KANSL3 HCFC1	7.19e-06	12	113	3	20018852
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NUP214 CSMD3 MFAP3L YEATS2 MEGF8 SYVN1 SPEN EPB41L1 SON	7.70e-06	407	113	9	12693553
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	POU2F1 BPTF ZNF608 SPEN FOXK1	7.86e-06	83	113	5	28794006
Pubmed	MOF-associated complexes ensure stem cell identity and Xist repression.	MSL2 KANSL3 HCFC1	9.33e-06	13	113	3	24842875
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	RANBP2 GATAD2A ZMYND8 SRCAP BPTF HCFC1	1.01e-05	150	113	6	28242625
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	1.05e-05	2	113	2	7513696
Pubmed	Collagen types XII and XIV are present in basement membrane zones during human embryonic development.	COL12A1 COL14A1	1.05e-05	2	113	2	15609093
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	1.05e-05	2	113	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	1.05e-05	2	113	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	1.05e-05	2	113	2	15563276
Pubmed	Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16).	POU2F1 HCFC1	1.05e-05	2	113	2	8454622
Pubmed	Dynamic interactions between E-cadherin and Ankyrin-G mediate epithelial cell polarity maintenance.	ANK3 CDH1	1.05e-05	2	113	2	37891324
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	1.05e-05	2	113	2	17621824
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	1.05e-05	2	113	2	18475301
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.05e-05	2	113	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	1.05e-05	2	113	2	24317696
Pubmed	Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study.	KRT5 CD44	1.05e-05	2	113	2	25143125
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	1.05e-05	2	113	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	1.05e-05	2	113	2	35776514
Pubmed	Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis.	CD44 CDH1	1.05e-05	2	113	2	24084461
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	1.05e-05	2	113	2	24327612
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	1.05e-05	2	113	2	28321513
Pubmed	Correlation between E-cadherin and CD44 adhesion molecules expression and cervical lymph node metastasis in oral tongue SCC: Predictive significance or not.	CD44 CDH1	1.05e-05	2	113	2	21632186
Pubmed	Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.	PPP1R12A LPA	1.05e-05	2	113	2	18776185
Pubmed	FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression.	CD44 CDH1	1.05e-05	2	113	2	30963578
Pubmed	Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma.	KRT5 CD44	1.05e-05	2	113	2	26990746
Pubmed	Lubricin/Proteoglycan 4 Binding to CD44 Receptor: A Mechanism of the Suppression of Proinflammatory Cytokine-Induced Synoviocyte Proliferation by Lubricin.	CD44 PRG4	1.05e-05	2	113	2	25708025
Pubmed	Protein 4.1 and the control of ion channels.	EPB41 EPB41L1	1.05e-05	2	113	2	19272819
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	1.05e-05	2	113	2	28607090
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	1.05e-05	2	113	2	10973822
Pubmed	Characterization of the effects of cross-linking of macrophage CD44 associated with increased phagocytosis of apoptotic PMN.	TIAM1 CD44	1.05e-05	2	113	2	22427969
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	1.05e-05	2	113	2	31030254
Pubmed	HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion.	HUWE1 TIAM1	1.05e-05	2	113	2	25543140
Pubmed	Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.	POU2F1 HCFC1	1.05e-05	2	113	2	9199328
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	1.05e-05	2	113	2	23527003
Pubmed	RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia.	RANBP2 ALK	1.05e-05	2	113	2	24613277
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	1.05e-05	2	113	2	16540890
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	1.05e-05	2	113	2	27845589
Pubmed	The COL12A1 and COL14A1 genes and Achilles tendon injuries.	COL12A1 COL14A1	1.05e-05	2	113	2	17960519
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	1.05e-05	2	113	2	27435107
Pubmed	E-cadherin negatively regulates CD44-hyaluronan interaction and CD44-mediated tumor invasion and branching morphogenesis.	CD44 CDH1	1.05e-05	2	113	2	12511569
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.05e-05	2	113	2	23544943
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	1.05e-05	2	113	2	26871672
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	1.05e-05	2	113	2	11988092
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	1.05e-05	2	113	2	14690056
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	1.05e-05	2	113	2	11587997
Pubmed	Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma.	RANBP2 ALK	1.05e-05	2	113	2	24470379
Interaction	NUP43 interactions	RANBP2 ATN1 GATAD2A PPP1R12A ZMYND8 MUC19 NUP214 SRCAP POM121C CSMD3 MSL2 KANSL3 YEATS2 BPTF ZNF608 NFRKB HCFC2 RAPGEF2 SPEN HCFC1 SON	1.23e-11	625	107	21	int:NUP43
Interaction	PHF20L1 interactions	ATN1 GATAD2A ZMYND8 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	6.09e-09	75	107	8	int:PHF20L1
Interaction	PHF20 interactions	ATN1 KDM6B KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	1.23e-08	53	107	7	int:PHF20
Interaction	SETD1A interactions	KLF12 ATN1 KANSL3 YEATS2 ZNF608 TCERG1 HCFC2 HCFC1 EPB41L1	3.09e-07	170	107	9	int:SETD1A
Interaction	RERE interactions	ATN1 ZMYND8 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	6.35e-07	93	107	7	int:RERE
Interaction	ZNF608 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 CDH1 HCFC1	6.35e-07	93	107	7	int:ZNF608
Interaction	ATN1 interactions	ATN1 ZMYND8 KANSL3 YEATS2 MEGF8 ZNF608 HCFC2 SYVN1 HCFC1	6.90e-07	187	107	9	int:ATN1
Interaction	KAT8 interactions	ATN1 MSL2 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	7.34e-07	95	107	7	int:KAT8
Interaction	ZZZ3 interactions	KLF12 ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1 MAML3	7.68e-07	139	107	8	int:ZZZ3
Interaction	ELF2 interactions	KLF12 POU2F1 SRCAP KANSL3 BPTF NFRKB HCFC2 FOXK1	1.84e-06	156	107	8	int:ELF2
Interaction	KANSL2 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	1.94e-06	70	107	6	int:KANSL2
Interaction	KAT14 interactions	KLF12 ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	2.24e-06	112	107	7	int:KAT14
Interaction	SETD1B interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	2.91e-06	75	107	6	int:SETD1B
Interaction	KMT2B interactions	KLF12 ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	6.03e-06	130	107	7	int:KMT2B
Interaction	KANSL3 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	6.48e-06	86	107	6	int:KANSL3
Interaction	CXXC1 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1 EPB41L1	6.67e-06	132	107	7	int:CXXC1
Interaction	HCFC2 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	9.58e-06	92	107	6	int:HCFC2
Interaction	TADA3 interactions	KLF12 ATN1 STAU1 KANSL3 YEATS2 ZNF608 HCFC2	1.03e-05	141	107	7	int:TADA3
Interaction	KANSL1 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	1.22e-05	96	107	6	int:KANSL1
Interaction	RBBP5 interactions	ATN1 GATAD2A KDM6B STAU1 KANSL3 YEATS2 HCFC2 SPEN HCFC1	2.25e-05	287	107	9	int:RBBP5
Interaction	HCFC1 interactions	ATN1 POU2F1 KANSL3 YEATS2 ZNF608 HCFC2 CDH1 HCFC1 FOXK1	2.65e-05	293	107	9	int:HCFC1
Interaction	MBIP interactions	KLF12 ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	2.85e-05	165	107	7	int:MBIP
Interaction	NLE1 interactions	GATAD2A MBNL1 STAU1 KANSL3 YEATS2 NFRKB SPEN SON	2.96e-05	228	107	8	int:NLE1
Interaction	SLFN11 interactions	FILIP1 RANBP2 HECW1 NUP214 KDM6B AP3B1 BPTF TIAM1 TCERG1 SON	3.20e-05	376	107	10	int:SLFN11
Interaction	MCRS1 interactions	ATN1 ZBTB22 KANSL3 YEATS2 ZNF608 NFRKB HCFC2 HCFC1	3.67e-05	235	107	8	int:MCRS1
Interaction	TERF2IP interactions	GATAD2A SFSWAP ZMYND8 SRCAP KANSL3 YEATS2 BPTF ZNF608 TCERG1 NFRKB SPEN HCFC1	3.69e-05	552	107	12	int:TERF2IP
Interaction	KMT2A interactions	KLF12 ATN1 NUP214 KDM6B KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	4.54e-05	314	107	9	int:KMT2A
Interaction	KCNA3 interactions	RANBP2 AFF2 ANK3 SPTBN1 CPD NUP214 AP3B1 STAU1 YEATS2 TCERG1 SPEN HCFC1 EPB41 EPB41L1 OTOG	5.60e-05	871	107	15	int:KCNA3
Interaction	ELF1 interactions	SRCAP KANSL3 BPTF NFRKB HCFC2 FOXK1	5.72e-05	126	107	6	int:ELF1
Interaction	CIC interactions	KLF12 RANBP2 GATAD2A SFSWAP SPTBN1 ZMYND8 HUWE1 MSL2 TCERG1 HCFC1 FOXK1 EPB41 SON	5.80e-05	673	107	13	int:CIC
Interaction	YAP1 interactions	ATN1 ANK3 HECW1 PPP1R12A SPTBN1 HUWE1 SRCAP NEK9 BPTF TCERG1 NFRKB RAPGEF2 SPEN CDH1 HCFC1 EPB41 DCP1A	6.26e-05	1095	107	17	int:YAP1
Interaction	ARF6 interactions	KIF13B ANK3 SPTBN1 KIAA1549 CPD AP3B1 STAU1 TIAM1 CD44 LAMP3 EPB41 EPB41L1	6.34e-05	584	107	12	int:ARF6
Interaction	KLF8 interactions	POU2F1 POM121C STAU1 KANSL3 YEATS2 BPTF NFRKB SPEN FOXK1	6.51e-05	329	107	9	int:KLF8
Interaction	SMC5 interactions	RANBP2 GATAD2A SFSWAP MBNL1 ZMYND8 NUP214 STAU1 YEATS2 BPTF TCERG1 NFRKB SPEN ALK HCFC1 EPB41 SON	7.41e-05	1000	107	16	int:SMC5
Interaction	WWTR1 interactions	ANK3 PPP1R12A SRCAP AP3B1 NEK9 YEATS2 BPTF TCERG1 HCFC1 EPB41	8.39e-05	422	107	10	int:WWTR1
Interaction	ASH2L interactions	KDM6B SRCAP KANSL3 YEATS2 HCFC2 HCFC1 FOXK1 MYBPC1	8.53e-05	265	107	8	int:ASH2L
Interaction	KRT32 interactions	KRT3 KRT5 GATAD2A KRT86	8.66e-05	44	107	4	int:KRT32
Interaction	RNF43 interactions	RANBP2 ANK3 HECW1 KIAA1549 CPD POM121C C6orf132 TCERG1 TMEM131 CDH1	9.25e-05	427	107	10	int:RNF43
Interaction	MYBPC2 interactions	RANBP2 COL12A1 ALK MYBPC1	9.46e-05	45	107	4	int:MYBPC2
Interaction	EPB41L3 interactions	SPTBN1 HUWE1 AP3B1 STAU1 CD44 CDH1 EPB41 EPB41L1	1.02e-04	272	107	8	int:EPB41L3
Interaction	MEN1 interactions	KIF13B ATN1 GATAD2A ZMYND8 SRCAP POM121C KANSL3 BPTF ZNF608 TCERG1 HCFC2 SPEN HCFC1 FOXK1 DCP1A SON	1.03e-04	1029	107	16	int:MEN1
Interaction	HNF4A interactions	MUC19 SRCAP KANSL3 YEATS2 BPTF ZNF608 NFRKB SPEN	1.10e-04	275	107	8	int:HNF4A
Interaction	SHH interactions	BOC SYVN1 CDON	1.12e-04	18	107	3	int:SHH
Interaction	DHRS2 interactions	SI CCDC141 STAU1 TCERG1 CD44	1.38e-04	93	107	5	int:DHRS2
Interaction	YY1 interactions	KLF12 ZMYND8 SRCAP MSL2 KANSL3 YEATS2 BPTF NFRKB HCFC2 HCFC1	1.53e-04	454	107	10	int:YY1
Interaction	GCNT2 interactions	COL12A1 COL14A1 SYVN1 FAM8A1	1.67e-04	52	107	4	int:GCNT2
Interaction	TFCP2L1 interactions	GATAD2A KANSL3 YEATS2 BPTF HCFC1	1.85e-04	99	107	5	int:TFCP2L1
Interaction	HDAC2 interactions	KRT5 GATAD2A PPP1R12A ZMYND8 HUWE1 WNK1 KANSL3 BPTF CD44 COL14A1 SPEN CDH1 HCFC1 FOXK1	1.93e-04	865	107	14	int:HDAC2
Interaction	NAA40 interactions	RANBP2 PPP1R12A ZMYND8 NUP214 SRCAP POM121C WNK1 NEK9 STAU1 YEATS2 TCERG1 HCFC1 EPB41 DCP1A SON	2.02e-04	978	107	15	int:NAA40
Interaction	MEX3A interactions	SPTBN1 ZMYND8 ZBTB22 HUWE1 STAU1 YEATS2 EYS FOXK1 SON	2.09e-04	384	107	9	int:MEX3A
Interaction	NFIX interactions	POU2F1 SRCAP KANSL3 BPTF ZNF608 NFRKB SPEN	2.11e-04	227	107	7	int:NFIX
Interaction	YWHAH interactions	KIF13B SFSWAP PPP1R12A SPTBN1 HUWE1 WNK1 C6orf132 TIAM1 MEGF8 TCERG1 RAPGEF2 FOXK1 EPB41 EPB41L1 DCP1A OTOG	2.27e-04	1102	107	16	int:YWHAH
Interaction	PPIA interactions	KRT3 GATAD2A ANK3 PPP1R12A ZMYND8 POU2F1 HUWE1 KANSL3 YEATS2 BPTF CD44 HCFC1 EPB41 DCP1A	2.53e-04	888	107	14	int:PPIA
Interaction	FHL2 interactions	KLF12 MBNL1 WNK1 YEATS2 BMPR2 SPEN FOXK1 DCP1A MYBPC1	2.62e-04	396	107	9	int:FHL2
Interaction	KBTBD4 interactions	RANBP2 HUWE1 WNK1 NEK9 TCERG1 NFRKB HCFC1 FOXK1	2.84e-04	316	107	8	int:KBTBD4
Interaction	YEATS2 interactions	ATN1 KANSL3 YEATS2 ZNF608 HCFC2 HCFC1	2.86e-04	169	107	6	int:YEATS2
Interaction	PAK4 interactions	KIF13B GATAD2A NEK9 STAU1 LAMP3 CDH1	2.86e-04	169	107	6	int:PAK4
Interaction	RCOR1 interactions	KLF12 RANBP2 GATAD2A PPP1R12A ZMYND8 HUWE1 NEK9 YEATS2 SPEN DCP1A	3.00e-04	494	107	10	int:RCOR1
Interaction	DYNLT1 interactions	KLF12 KIAA0586 HAVCR1 BMPR2 NFRKB SPEN HCFC1	3.03e-04	241	107	7	int:DYNLT1
Interaction	ACTR8 interactions	SRCAP BMPR2 NFRKB HCFC1	3.31e-04	62	107	4	int:ACTR8
Interaction	RND1 interactions	KRT5 SPTBN1 KIAA1549 CPD BMPR2 CD44 EPB41L1	3.43e-04	246	107	7	int:RND1
Interaction	ELF4 interactions	SRCAP KANSL3 BPTF NFRKB FOXK1	3.71e-04	115	107	5	int:ELF4
Interaction	AP3S2 interactions	HUWE1 AP3B1 STAU1	4.33e-04	28	107	3	int:AP3S2
Interaction	CAV1 interactions	KIF13B ANK3 SPTBN1 KIAA1549 CPD BMPR2 TIAM1 CD44 LAMP3 CDH1 EPB41 EPB41L1	4.61e-04	724	107	12	int:CAV1
Interaction	BAG2 interactions	KIF13B PPP1R12A MBNL1 POU2F1 HUWE1 WNK1 YEATS2 BPTF NFRKB SPEN FOXK1	4.70e-04	622	107	11	int:BAG2
Interaction	NUP50 interactions	RANBP2 SFSWAP NUP214 YEATS2 TCERG1 SPEN EPB41L1 SON	4.72e-04	341	107	8	int:NUP50
Interaction	DIRAS3 interactions	ANK3 SPTBN1 KIAA1549 CPD HUWE1 TIAM1 EPB41L1	5.00e-04	262	107	7	int:DIRAS3
Interaction	ESRRB interactions	GATAD2A ZMYND8 STAU1 KANSL3 BPTF NFRKB HCFC1	5.00e-04	262	107	7	int:ESRRB
Interaction	KRT28 interactions	KRT3 KRT5 KRT86	5.32e-04	30	107	3	int:KRT28
Interaction	YWHAZ interactions	KIF13B PPP1R12A SPTBN1 HUWE1 AP3B1 WNK1 C6orf132 STAU1 MSL2 TIAM1 RAPGEF2 CDH1 FOXK1 EPB41 EPB41L1 DCP1A OTOG	5.67e-04	1319	107	17	int:YWHAZ
Interaction	SNRNP40 interactions	ATN1 GATAD2A SFSWAP MBNL1 POM121C YEATS2 ZNF608 TCERG1 NFRKB SPEN SON	5.73e-04	637	107	11	int:SNRNP40
Interaction	DNAAF3 interactions	RANBP2 SYVN1	5.76e-04	7	107	2	int:DNAAF3
Interaction	HDAC4 interactions	KIF13B RANBP2 SPTBN1 NUP214 HUWE1 AP3B1 STAU1 TIAM1 TCERG1 NFRKB RAPGEF2 DCP1A	5.87e-04	744	107	12	int:HDAC4
Interaction	SCYL2 interactions	POU2F1 GORASP1 LAMP3 RAPGEF2 SPEN CDH1	6.11e-04	195	107	6	int:SCYL2
Cytoband	7q22	MUC3B MUC12 MUC3A	1.15e-04	38	113	3	7q22
Cytoband	14q23.1	KIAA0586 ARMH4 KCNH5	2.18e-04	47	113	3	14q23.1
Cytoband	21q22.11	TIAM1 KRTAP24-1 SON	4.94e-04	62	113	3	21q22.11
GeneFamily	CD molecules\|Mucins	MUC3B MUC19 MUC16 MUC5B MUC12 MUC17 MUC22 MUC3A MUC4 MUC5AC MUC6	1.83e-21	21	79	11	648
GeneFamily	Fibronectin type III domain containing	BOC COL12A1 PTPRQ COL14A1 SDK1 CDON MYBPC1	6.33e-06	160	79	7	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	BOC CADM2 MFAP3L SDK1 CDON MYBPC1	7.38e-05	161	79	6	593
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41 EPB41L1	1.12e-04	4	79	2	951
GeneFamily	Keratins, type II	KRT3 KRT5 KRT86	2.18e-04	27	79	3	609
GeneFamily	ATAC complex	YEATS2 HCFC1	1.43e-03	13	79	2	1058
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	HAVCR1 CRTAM CD44 LAMP3 CD68 CDH1 ALK	1.67e-03	394	79	7	471
GeneFamily	PDZ domain containing	PCLO TIAM1 GORASP1 RAPGEF2	4.43e-03	152	79	4	1220
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC5B MUC12 MUCL1 MUC17 MUC22 MUC3A MUC4 MUC5AC MUC6	1.84e-10	170	112	11	M5880
Coexpression	NABA_MATRISOME	COL12A1 MUC19 MUC16 MUC5B MUC12 EYS MUCL1 MEGF8 MUC17 LPA COL14A1 HCFC2 MUC22 MUC3A PRG4 MUC4 MUC5AC MUC6 HCFC1 OTOG	1.27e-08	1026	112	20	M5889
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC5B MFRP MUC17 MUC4 MUC5AC MUC6	4.08e-07	158	112	8	MM17063
Coexpression	NABA_MATRISOME_ASSOCIATED	MUC19 MUC16 MUC5B MUC12 MUCL1 MEGF8 MUC17 LPA HCFC2 MUC22 MUC3A MUC4 MUC5AC MUC6 HCFC1	7.48e-07	751	112	15	M5885
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	KLF12 ZMYND8 POU2F1 MSL2 BMPR2 CD44 EPB41 SON	2.32e-06	199	112	8	M7596
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	AFF2 ANK3 PCLO ZMYND8 MUC19 KIAA1549 POU2F1 CSMD3 CCDC141 CADM2 NRXN3 TCERG1 HCFC2 EPB41 EPB41L1 CDON ARMH4	4.62e-06	1106	112	17	M39071
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	PPP1R12A MBNL1 BMPR2 NRXN3 RAPGEF2 SDK1 MAML3	4.76e-06	155	112	7	M39246
Coexpression	NABA_MATRISOME	COL12A1 MUC19 MUC16 MUC5B MFRP MEGF8 MUC17 LPA COL14A1 HCFC2 PRG4 MUC4 MUC5AC MUC6 HCFC1 OTOG	6.07e-06	1008	112	16	MM17056
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	COL12A1 PPP1R12A SPTBN1 WNK1 BMPR2 RAPGEF2 MAML3	1.13e-05	177	112	7	M39245
Coexpression	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	SPTBN1 CCDC141 KANSL3 BMPR2 SPEN MUC4 SON	2.42e-05	199	112	7	M7451
Coexpression	GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN	ATN1 KRT86 NR4A3 CD44 CDH1 MUC4 MUC6	2.50e-05	200	112	7	M5156
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	RANBP2 MBNL1 ZMYND8 CPD WNK1 STAU1 BPTF TCERG1 CD44 LAMP3	4.20e-05	481	112	10	M3898
Coexpression	SUZUKI_RESPONSE_TO_TSA	PPP1R12A MBNL1 ZMYND8	5.91e-05	18	112	3	M1680
Coexpression	NABA_MATRISOME_ASSOCIATED	MUC19 MUC16 MUC5B MFRP MEGF8 MUC17 LPA HCFC2 MUC4 MUC5AC MUC6 HCFC1	7.67e-05	738	112	12	MM17058
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	KIF13B RANBP2 ANK3 SPTBN1 RAPGEF2 SDK1 MAML3	7.92e-05	240	112	7	M39236
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	FILIP1 KRT5 KLF12 GATAD2A ANK3 SFSWAP PPP1R12A CPD NUP214 HUWE1 KDM6B WNK1 MFAP3L NRXN3 COL14A1 CDH1 ALK DCP1A SON ARMH4	5.82e-09	818	109	20	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	KLF12 GATAD2A ANK3 SFSWAP CPD NUP214 KDM6B WNK1 COL14A1 ALK DCP1A SON	6.86e-07	385	109	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500	FILIP1 KLF12 ANK3 PPP1R12A CPD NUP214 KDM6B MFAP3L NRXN3 COL14A1 DCP1A	9.82e-06	416	109	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	AFF2 PPP1R12A PCLO POU2F1 NR4A3 AP3B1 WNK1 STAU1 MSL2 HAVCR1 TIAM1 TMEM131 CEP295 ABLIM2 MUC4 MUC6 MAML3	1.14e-05	989	109	17	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	BM Top 100 - trachea	KRT5 MUC16 CDH1 MUC4 MUC5AC	3.46e-05	72	109	5	BM Top 100 - trachea
CoexpressionAtlas	BM Top 100 - bronchus	KRT5 MUC5B CDH1 MUC4 MUC5AC	4.49e-05	76	109	5	BM Top 100 - bronchus
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	PCLO KIAA0586 MBNL1 POU2F1 AP3B1 TIAM1 MUC4 MUC6 MAML3 EPB41 CDON	4.59e-05	492	109	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	PPP1R12A PCLO KIAA0586 SRCAP AP3B1 WNK1 BPTF CEP295 RAPGEF2 SDK1 MAML3 SON	5.54e-05	595	109	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	FILIP1 KLF12 PPP1R12A NR4A3 CPD NUP214 HUWE1 KDM6B AP3B1 MFAP3L COL14A1 DCP1A SON ARMH4	6.97e-05	811	109	14	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	PPP1R12A KIAA0586 POU2F1 AP3B1 WNK1 BPTF TMEM131 CEP295 RAPGEF2 MAML3 EPB41L1 SON	9.39e-05	629	109	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	KLF12 ANK3 CPD NUP214 KDM6B COL14A1 DCP1A	1.03e-04	209	109	7	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	ANK3 KIAA1549 CPD NUP214 HUWE1 CCDC141 MFAP3L BPTF DCP1A	1.48e-04	379	109	9	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	KLF12 SFSWAP SPTBN1 CPD KDM6B CD44 COL14A1 CEP295 CDON	2.38e-04	404	109	9	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	KLF12 SFSWAP SPTBN1 CPD KDM6B SRCAP CEP295 CDON MYBPC1	2.47e-04	406	109	9	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	KLF12 SFSWAP SPTBN1 CPD KDM6B SRCAP CEP295 CDON MYBPC1	2.80e-04	413	109	9	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	FILIP1 KLF12 PPP1R12A NR4A3 CPD HUWE1 MFAP3L NRXN3 COL14A1 HCFC2 FOXK1 SON ARMH4	3.17e-04	826	109	13	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC EPB41L1 MGAM2 MYBPC1	9.58e-10	183	112	9	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 HECW1 PCLO MUC5B CSMD3 CADM2 PTPRQ SDK1 OTOG	1.01e-09	184	112	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 HECW1 PCLO MUC5B CSMD3 CADM2 PTPRQ SDK1 OTOG	1.01e-09	184	112	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 HECW1 PCLO MUC5B CSMD3 CADM2 PTPRQ SDK1 OTOG	1.01e-09	184	112	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC MGAM2 MYBPC1	1.79e-08	179	112	8	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC MGAM2 MYBPC1	1.87e-08	180	112	8	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC MGAM2 MYBPC1	1.87e-08	180	112	8	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC MGAM2 MYBPC1	2.22e-08	184	112	8	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	IPF-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MUC5B C6orf132 NRXN3 ZNF608 CDH1 MUC4 MUC5AC SDK1	2.85e-08	190	112	8	c29dabf0826663b9d6df51a7af9b76592090e44c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CCDC141 ESYT3 ZNF608 PTPRQ LAMP3 MAP3K13 CDH1	2.97e-08	191	112	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	BOC FILIP1 ATN1 ANK3 CCDC141 NRXN3 LAMP3 CDH1	3.77e-08	197	112	8	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KRT5 ANK3 PCLO SPTBN1 C6orf132 CDH1 MUC4 EPB41L1	4.24e-08	200	112	8	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 PCLO MUC16 CPD MUC5B MAP3K13 CDH1 MAML3	4.24e-08	200	112	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Bronchus_Control_(B.)-Epithelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	KRT5 ANK3 MUC16 MUC5B C6orf132 CDH1 MUC4 MUC5AC	4.24e-08	200	112	8	f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KRT5 ANK3 PCLO MUC16 C6orf132 CDH1 MUC4 EPB41L1	4.24e-08	200	112	8	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	BOC MUC16 PTPRQ ABLIM2 PRG4 CDON KCNH5	1.41e-07	156	112	7	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B NRXN3 ZNF608 MUC4 MUC5AC SDK1	4.00e-07	182	112	7	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ANK3 NRXN3 ZNF608 MAP3K13 CDH1 MUC4 SDK1	4.47e-07	185	112	7	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	IPF-Epithelial-Goblet\|IPF / Disease state, Lineage and Cell class	MUC5B C6orf132 NRXN3 ZNF608 CDH1 MUC4 MUC5AC	5.34e-07	190	112	7	e41dd5a997ad9952810ffecb57737c03ea1d88b3
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	ANK3 MUC16 MUC5B NRXN3 MUC4 MUC5AC SDK1	5.34e-07	190	112	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	ANK3 PCLO CCDC141 ESYT3 LAMP3 MAP3K13 CDH1	5.54e-07	191	112	7	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 ANK3 CCDC141 ZNF608 LAMP3 MAP3K13 CDH1	5.54e-07	191	112	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KRT5 ANK3 MUC5B ZNF608 CDH1 MUC4 MUC5AC	5.73e-07	192	112	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	COPD-Epithelial-Goblet\|COPD / Disease state, Lineage and Cell class	MUC16 MUC5B C6orf132 MUCL1 CDH1 MUC4 SDK1	5.73e-07	192	112	7	93b2ca0a97776d28c7e8f1a0642c4b63a5554aab
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	FILIP1 ANK3 CCDC141 NRXN3 LAMP3 CDH1 CDON	6.81e-07	197	112	7	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BOC FILIP1 ANK3 CCDC141 NRXN3 LAMP3 CDH1	6.81e-07	197	112	7	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FILIP1 ANK3 DYNAP CCDC141 NRXN3 CDH1 SON	6.81e-07	197	112	7	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 MUC16 MUC5B C6orf132 CDH1 MUC4 MUC5AC	7.29e-07	199	112	7	d04062d86643e5712cc2f519f4f36e643d404a16
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT5 MUC16 MUC5B C6orf132 CDH1 MUC4 MUC5AC	7.29e-07	199	112	7	a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 MUC16 MUC5B C6orf132 CDH1 MUC4 MUC5AC	7.29e-07	199	112	7	644197ff7e3299587881dd678836262e670ed4a8
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	BOC KIAA1549 WNK1 BPTF TMEM131 HCFC1 CDON	7.29e-07	199	112	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Bronchial_Biopsy-Epithelial\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	KRT5 ANK3 MUC16 C6orf132 CDH1 MUC4 MUC5AC	7.29e-07	199	112	7	ef5d8917c8d011184830a0b8197afc6266707b37
ToppCell	Severe_COVID-19-Epithelial-Basal/Club\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	KRT5 MUC16 MUC5B C6orf132 CDH1 MUC4 MUC5AC	7.29e-07	199	112	7	2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 MUC16 MUC5B C6orf132 CDH1 MUC4 MUC5AC	7.29e-07	199	112	7	fd364f43859b2e7a3e91ce6a1c430cc42ad26a49
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTBN1 MUC16 C6orf132 LAMP3 MAP3K13 CDH1 MUC4	7.54e-07	200	112	7	f386a86b127433cbac306950443355bd723080ff
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 ANK3 MUC16 C6orf132 LAMP3 CDH1 MUC4	7.54e-07	200	112	7	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTBN1 MUC16 C6orf132 LAMP3 MAP3K13 CDH1 MUC4	7.54e-07	200	112	7	1c02a7f4047d1d2208cc522c6bb4a4989d7845bb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTBN1 MUC16 C6orf132 LAMP3 MAP3K13 CDH1 MUC4	7.54e-07	200	112	7	b75154417c215b8853186bff46d624ebd387ac4f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 MUC16 CPD MUC5B MAP3K13 CDH1 MAML3	7.54e-07	200	112	7	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTBN1 MUC16 C6orf132 LAMP3 MAP3K13 CDH1 MUC4	7.54e-07	200	112	7	03051d2190244208905e1611019d4b8fd200bae0
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC16 MFAP3L GSN-AS1 MUC22 ALK KCNH5	1.26e-06	136	112	6	27a41463e6f16deb5b1d4f17fefded9959038c07
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MFAP3L GSN-AS1 MUC22 ALK KCNH5	1.26e-06	136	112	6	88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	MUC16 CSMD3 ADGRG4 CADM2 EYS NRXN3	1.43e-06	139	112	6	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SI CSMD3 CADM2 EYS ALK KCNH5	2.22e-06	150	112	6	0205318a870e091add66ee4305747dda9f51510d
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	BOC NR4A3 KDM6B POM121C C6orf132 RAPGEF2	2.69e-06	155	112	6	335cd798afbaa0a3a3e1dc558a81cfa32da48983
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 CADM2 EYS NRXN3 ALK KCNH5	3.11e-06	159	112	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	RANBP2 ANK3 SPTBN1 MBNL1 KANSL3 EPB41	3.47e-06	162	112	6	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 CADM2 EYS NRXN3 ALK KCNH5	3.59e-06	163	112	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BOC MUC16 PTPRQ PRG4 CDON KCNH5	3.72e-06	164	112	6	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	KRT5 PCLO MUC16 MFAP3L PTPRQ PRG4	3.99e-06	166	112	6	4d63c758d46e73311b864148c646bf081498dee7
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	KRT5 PCLO MUC16 MFAP3L PTPRQ PRG4	3.99e-06	166	112	6	4160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCell	Control\|World / group, cell type (main and fine annotations)	FILIP1 ANK3 CCDC141 NRXN3 CDH1 MUC5AC	4.27e-06	168	112	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SI CSMD3 CADM2 EYS ALK MYBPC1	4.73e-06	171	112	6	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AP3B1 CCDC141 GORASP1 CEP295 MAP3K13 RAPGEF2	4.89e-06	172	112	6	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B NRXN3 MUC4 MUC5AC SDK1	5.06e-06	173	112	6	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B AFF2 KRT86 PCLO KIAA1549 MUC4	5.23e-06	174	112	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BOC ANK3 MUC16 CADM2 MUC4 MUC5AC	5.23e-06	174	112	6	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	MUC16 MUC5B NRXN3 MUC5AC SDK1 CDON	5.23e-06	174	112	6	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	AP3B1 CCDC141 GORASP1 CEP295 MAP3K13 RAPGEF2	5.40e-06	175	112	6	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC5B NRXN3 ZNF608 MUC4 MUC5AC SDK1	5.77e-06	177	112	6	779ba86f53650772755b52460be03f18bb204e55
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC5B NRXN3 ZNF608 MUC4 MUC5AC SDK1	5.77e-06	177	112	6	0f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCell	facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 AFF2 WNK1 CCDC141 CDH1 EPB41L1	6.35e-06	180	112	6	fc5b9d0e3215652e490ca72d69f776e9725608b2
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BOC FILIP1 ANK3 NRXN3 LAMP3 CDH1	6.35e-06	180	112	6	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 AFF2 WNK1 CCDC141 CDH1 EPB41L1	6.35e-06	180	112	6	6763b22f2383931c747b37cd0ae2f60b08f64d90
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KRT5 MUC16 PTPRQ PRG4 CDON KCNH5	6.56e-06	181	112	6	65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KRT5 MUC16 PTPRQ PRG4 CDON KCNH5	6.56e-06	181	112	6	eaac7d58117eddfff06b25521efc431c1351d592
ToppCell	COPD-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT5 ANK3 PTPRQ CDH1 MUC4 SDK1	6.56e-06	181	112	6	6d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT5 ANK3 C6orf132 PTPRQ CDH1 SDK1	6.77e-06	182	112	6	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	KRT5 ANK3 C6orf132 PTPRQ CDH1 SDK1	6.77e-06	182	112	6	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ANK3 KRT86 CCDC141 ESYT3 LAMP3 CDH1	6.98e-06	183	112	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	MUC16 MUC5B NRXN3 MUC4 MUC5AC SDK1	6.98e-06	183	112	6	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KRT5 MUC16 PTPRQ PRG4 MUC5AC CDON	6.98e-06	183	112	6	9d5a363fbe6f0a1668c9d584df65ee1c283349c7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KRT5 MUC16 PTPRQ PRG4 MUC5AC CDON	6.98e-06	183	112	6	c5caac6ed6c8d67f5c336281d9fd903976509445
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BOC FILIP1 ANK3 NRXN3 LAMP3 CDH1	7.20e-06	184	112	6	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC4 MUC5AC MUC6 SDK1	7.20e-06	184	112	6	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	Control-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	KRT86 MUC5B C6orf132 CDH1 MUC4 MUC5AC	7.43e-06	185	112	6	9a793e6016295a63820e9d7563f195494ac692e7
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FILIP1 ANK3 NRXN3 LAMP3 CDH1 CDON	7.43e-06	185	112	6	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MUC16 MUC5B C6orf132 CDH1 MUC4 SDK1	7.66e-06	186	112	6	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BOC FILIP1 ANK3 NRXN3 LAMP3 CDH1	7.66e-06	186	112	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 KLF12 COL12A1 AFF2 EYS ALK	7.90e-06	187	112	6	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZMYND8 NRXN3 MUCL1 CD44 TAF4B SDK1	7.90e-06	187	112	6	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BOC RANBP2 MBNL1 WNK1 TIAM1 EPB41	7.90e-06	187	112	6	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AFF2 HECW1 KIAA1549 HAVCR1 MAP3K13 SDK1	7.90e-06	187	112	6	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	ANK3 MBNL1 CCDC141 ESYT3 CD44 LAMP3	7.90e-06	187	112	6	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RANBP2 MBNL1 HUWE1 TMEM131 RAPGEF2 SPEN	8.14e-06	188	112	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	ANK3 KRT86 CCDC141 ESYT3 LAMP3 CDH1	8.14e-06	188	112	6	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT5 MUC5B DYNAP C6orf132 CDH1 MUC4	8.39e-06	189	112	6	ee15b4fb3a1cfda80bcf210a23f04f242594015e
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT5 MUC5B DYNAP C6orf132 CDH1 MUC4	8.39e-06	189	112	6	dc6f6fae84347d145bea71b49eaeeb3028e9c4ae
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FILIP1 COL12A1 ANK3 PRG4 SDK1 CDON	8.39e-06	189	112	6	c392491aabe8a3e90974ab2ea123bbbe5200439d
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	KRT5 ANK3 MUC5B ZNF608 MUC4 MUC5AC	8.39e-06	189	112	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	COVID-19-Epithelial_cells-Tuft-like\|COVID-19 / group, cell type (main and fine annotations)	KRT5 MUC5B C6orf132 CDH1 MUC4 MUC5AC	8.39e-06	189	112	6	2ffbe79fe3c3f22b1cb4269726b9eb5519be84a7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AFF2 KIAA1549 HAVCR1 ZNF608 MAP3K13 SDK1	8.65e-06	190	112	6	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MFAP3L CD44 PRG4 SDK1 EPB41L1 CDON	8.91e-06	191	112	6	5ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	ANK3 KRT86 C6orf132 ZNF608 CDH1 MUC4	9.18e-06	192	112	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	GATAD2A KDM6B C6orf132 HAVCR1 CD44 ABLIM2	9.18e-06	192	112	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	ANK3 PCLO CCDC141 NRXN3 LAMP3 MAP3K13	9.18e-06	192	112	6	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RANBP2 POU2F1 CPD HUWE1 BPTF SON	9.46e-06	193	112	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 KRT86 C6orf132 TIAM1 CDH1 SDK1	9.46e-06	193	112	6	a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCell	background-Cholangiocytes\|background / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 KRT86 PCLO CCDC141 C6orf132 MUC6	9.46e-06	193	112	6	9152241073dbe02ac2c11d86bec9b5b529196f6e
ToppCell	Club_cells\|World / lung cells shred on cell class, cell subclass, sample id	MUC16 MUC5B ZNF608 CDH1 MUC4 MUC5AC	9.46e-06	193	112	6	9d3165dc5763a07a7d873f497624d9d6528fa2db
Drug	rioprostil	MUC3B MUC12 MUCL1 MUC3A MUC5AC ALK	9.07e-09	32	110	6	CID005311413
Drug	cellobiitol	MUC3B MUC12 MUCL1 MUC3A MUC4 MUC5AC	2.28e-08	37	110	6	CID000003871
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	KIF13B ATN1 ANK3 ZMYND8 SRCAP WNK1 NFRKB CD44 CDH1	2.66e-07	183	110	9	4843_UP
Drug	inulin	MUC3B MUC12 MUCL1 LPA CDH1 MUC3A MUC4 MUC5AC	2.73e-07	133	110	8	CID000024763
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	KIF13B AFF2 ATN1 WNK1 KANSL3 NRXN3 TIAM1 MAP3K13 HCFC1	4.17e-07	193	110	9	4240_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	KLF12 AFF2 ANK3 HECW1 SRCAP MFAP3L BMPR2 TIAM1 EPB41	5.16e-07	198	110	9	3059_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	PPP1R12A PCLO WNK1 BPTF CD44 RAPGEF2 SPEN SON	2.48e-06	178	110	8	3998_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	ANK3 SFSWAP MBNL1 BPTF BMPR2 RAPGEF2 SPEN SON	2.58e-06	179	110	8	4585_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	SFSWAP PPP1R12A PCLO BPTF CD44 RAPGEF2 SPEN SON	3.72e-06	188	110	8	6735_DN
Drug	Gastrin tetrapeptide	MUC3B MUC12 MUCL1 MUC3A MUC5AC	4.28e-06	50	110	5	CID000005415
Drug	mucic acid	MUC3B MUC12 HAVCR1 MUCL1 MUC3A MUC5AC	4.35e-06	88	110	6	CID000000607
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	SPTBN1 SRCAP WNK1 CD44 LAMP3 RAPGEF2 SPEN EPB41L1	5.25e-06	197	110	8	2259_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; PC3; HT_HG-U133A	ATN1 SI HUWE1 MFAP3L CSN3 MAP3K13 MUC4 MUC6	5.45e-06	198	110	8	4261_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SPTBN1 NR4A3 CPD SRCAP WNK1 NEK9 COL14A1 MUC5AC	5.66e-06	199	110	8	7234_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	SPTBN1 ZMYND8 SRCAP MFAP3L NRXN3 CDH1 ALK HCFC1	5.66e-06	199	110	8	4562_DN
Drug	AC1L1C2F	COL12A1 MFRP CD44 LAMP3 COL14A1 MUC5AC	1.58e-05	110	110	6	CID000001711
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	PPP1R12A KIAA0586 POU2F1 YEATS2 BPTF TIAM1 RAPGEF2	1.98e-05	171	110	7	7535_DN
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	SFSWAP POU2F1 NR4A3 KDM6B BPTF HCFC1 SON	2.22e-05	174	110	7	1302_UP
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A	SPTBN1 HUWE1 SRCAP NRXN3 CSN3 NFRKB MAP3K13	3.52e-05	187	110	7	4581_UP
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ATN1 ZMYND8 NR4A3 WNK1 NEK9 MUC5AC ALK	3.76e-05	189	110	7	2231_UP
Drug	guanidine hydrochloride	MUC3B MUC12 MUCL1 MUC3A MUC4 MUC5AC	3.89e-05	129	110	6	CID000005742
Drug	Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A	KIF13B SPTBN1 KDM6B SRCAP MFAP3L NFRKB CD44	4.59e-05	195	110	7	3459_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	ATN1 ZMYND8 NUP214 MEGF8 CSN3 MAP3K13 HCFC1	4.59e-05	195	110	7	4272_UP
Drug	Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A	KLF12 SPTBN1 HUWE1 KDM6B NEK9 NFRKB CDH1	4.74e-05	196	110	7	4600_UP
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ATN1 SPTBN1 ZMYND8 KDM6B MFAP3L CD44 HCFC1	4.90e-05	197	110	7	6204_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	ATN1 ZMYND8 NEK9 MEGF8 COL14A1 MAP3K13 CDH1	4.90e-05	197	110	7	4266_UP
Drug	Harpagoside [19210-12-9]; Up 200; 8uM; PC3; HT_HG-U133A	KLF12 ZMYND8 KDM6B MFAP3L COL14A1 MUC6 HCFC1	4.90e-05	197	110	7	6636_UP
Drug	Thyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A	KLF12 HECW1 SI NUP214 HUWE1 NRXN3 COL14A1	4.90e-05	197	110	7	4069_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	ATN1 ANK3 AP3B1 MFAP3L CD44 TAF4B MUC5AC	5.05e-05	198	110	7	1648_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	ZMYND8 NUP214 SRCAP NEK9 TAF4B RAPGEF2 ALK	5.05e-05	198	110	7	4353_DN
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	KIAA0586 SRCAP WNK1 MFAP3L TAF4B HCFC1 EPB41L1	5.05e-05	198	110	7	2749_DN
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ATN1 SPTBN1 SRCAP NEK9 MFAP3L TIAM1 CDON	5.05e-05	198	110	7	1529_UP
Drug	arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A	ATN1 ANK3 SPTBN1 SRCAP TIAM1 HCFC2 EPB41L1	5.05e-05	198	110	7	594_DN
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A	KIF13B ATN1 SPTBN1 COL14A1 MUC6 HCFC1 CDON	5.05e-05	198	110	7	5837_UP
Drug	Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A	KLF12 AFF2 NEK9 MFAP3L MUC5AC MUC6 HCFC1	5.05e-05	198	110	7	6652_UP
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A	KLF12 PCLO MUC5B COL14A1 ALK MAML3 CDON	5.22e-05	199	110	7	3636_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A	KLF12 ZMYND8 CPD KDM6B CD44 RAPGEF2 MUC6	5.22e-05	199	110	7	7172_UP
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A	ATN1 KIAA0586 HUWE1 SRCAP MEGF8 ALK CDON	5.22e-05	199	110	7	3701_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A	KIF13B CPD STAU1 MSL2 NFRKB TAF4B SON	5.22e-05	199	110	7	1588_DN
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	KIF13B KDM6B MFAP3L TIAM1 CD44 TAF4B HCFC1	5.22e-05	199	110	7	2756_DN
Drug	CsCl	MUC3B WNK1 MUCL1 CD44 MUC3A MUC4	5.24e-05	136	110	6	CID000024293
Drug	Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A	ATN1 MUC5B KDM6B MEGF8 NFRKB ALK CDON	5.39e-05	200	110	7	3682_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	HECW1 HUWE1 KDM6B MFAP3L NRXN3 CSN3 MUC4	5.39e-05	200	110	7	4646_UP
Drug	Magdala red	PPP1R12A HUWE1 CD68	1.00e-04	19	110	3	CID000407912
Drug	testosterone enanthate	RANBP2 ANK3 PPP1R12A WNK1 MSL2 YEATS2 BPTF COL14A1 TAF4B RAPGEF2 SPEN	1.08e-04	575	110	11	ctd:C004648
Drug	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	ATN1 KDM6B SRCAP SPEN SON	1.51e-04	104	110	5	ctd:C000595015
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ATN1 NR4A3 SRCAP HCFC2 SPEN MAML3	1.68e-04	168	110	6	6087_UP
Drug	15 Z	RANBP2 ATN1	2.29e-04	5	110	2	CID005322065
Drug	AC1LAKND	BOC COL12A1 MFRP COL14A1	2.32e-04	62	110	4	CID000470146
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	PPP1R12A ZMYND8 MSL2 RAPGEF2 SPEN SON	2.59e-04	182	110	6	3887_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	PPP1R12A ZMYND8 BPTF TIAM1 RAPGEF2 CDH1	2.66e-04	183	110	6	7498_DN
Drug	17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A	AFF2 ATN1 ZMYND8 SRCAP MAP3K13 CDON	2.74e-04	184	110	6	5210_UP
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	ZMYND8 MSL2 BPTF RAPGEF2 SPEN SON	2.82e-04	185	110	6	1114_DN
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	KIF13B SRCAP MFAP3L CD44 LAMP3 CDON	2.91e-04	186	110	6	1533_UP
Drug	Lithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A	KLF12 PCLO ZMYND8 MFAP3L BMPR2 HCFC1	2.99e-04	187	110	6	2571_UP
Drug	Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A	KLF12 ATN1 HECW1 SRCAP KANSL3 MEGF8	2.99e-04	187	110	6	5258_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SFSWAP SPTBN1 MBNL1 WNK1 SPEN SON	2.99e-04	187	110	6	4302_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	SPTBN1 MBNL1 NEK9 BMPR2 TIAM1 CDH1	3.17e-04	189	110	6	3788_DN
Drug	Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A	SPTBN1 MBNL1 CPD NFRKB CD44 CDH1	3.26e-04	190	110	6	3352_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	ATN1 ANK3 WNK1 TIAM1 SPEN EPB41L1	3.26e-04	190	110	6	4322_DN
Drug	butyrate	KRT3 KRT5 MUC3B AFF2 KRT86 MUC12 MUCL1 CD44 CDH1 MUC3A MUC4 MUC5AC	3.37e-04	767	110	12	CID000000264
Drug	Oxo-1	BOC CRTAM	3.43e-04	6	110	2	CID000019716
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	PPP1R12A SPTBN1 AP3B1 WNK1 MFAP3L SPEN	3.44e-04	192	110	6	6435_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A	KIAA0586 CPD NUP214 SRCAP MFAP3L CD44	3.44e-04	192	110	6	6213_UP
Drug	STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A	MBNL1 MUC5B NFRKB CD44 CDH1 MUC6	3.54e-04	193	110	6	6869_DN
Drug	rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ZMYND8 HUWE1 NEK9 CD44 TAF4B MUC5AC	3.54e-04	193	110	6	921_UP
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A	KIF13B KLF12 NR4A3 HCFC2 RAPGEF2 HCFC1	3.54e-04	193	110	6	1715_UP
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A	GATAD2A SPTBN1 NEK9 MFAP3L CD44 HCFC1	3.54e-04	193	110	6	6223_UP
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A	MBNL1 NUP214 HUWE1 NEK9 NFRKB COL14A1	3.64e-04	194	110	6	4599_UP
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A	HECW1 KANSL3 CSN3 COL14A1 MAP3K13 ALK	3.64e-04	194	110	6	3938_UP
Drug	5155877; Up 200; 10uM; MCF7; HT_HG-U133A	ATN1 KDM6B SRCAP LAMP3 RAPGEF2 MUC5AC	3.64e-04	194	110	6	6549_UP
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	AP3B1 BMPR2 NRXN3 NFRKB TAF4B CDH1	3.64e-04	194	110	6	3747_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A	ATN1 KDM6B KANSL3 TIAM1 MAP3K13 HCFC1	3.64e-04	194	110	6	4249_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ANK3 MBNL1 ZMYND8 CPD SRCAP HCFC2	3.64e-04	194	110	6	4772_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A	ATN1 SPTBN1 CPD SRCAP WNK1 CD44	3.64e-04	194	110	6	4387_DN
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	KIF13B ZMYND8 NUP214 MFAP3L LAMP3 COL14A1	3.64e-04	194	110	6	6242_UP
Drug	Benfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A	ATN1 HECW1 NEK9 MFAP3L COL14A1 HCFC1	3.74e-04	195	110	6	4312_UP
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A	SPTBN1 WNK1 YEATS2 CD44 RAPGEF2 HCFC1	3.74e-04	195	110	6	3835_DN
Drug	Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A	ATN1 NUP214 KANSL3 NRXN3 TIAM1 HCFC1	3.74e-04	195	110	6	4201_DN
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; HL60; HT_HG-U133A	KLF12 ANK3 SPTBN1 SRCAP MFAP3L COL14A1	3.74e-04	195	110	6	2907_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	ATN1 MUC5B NUP214 SRCAP LAMP3 MUC5AC	3.74e-04	195	110	6	2875_UP
Drug	Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A	SRCAP WNK1 CD44 HCFC2 ALK HCFC1	3.74e-04	195	110	6	3358_DN
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	ATN1 ZMYND8 KANSL3 NRXN3 TIAM1 HCFC1	3.84e-04	196	110	6	4196_DN
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A	KIF13B KLF12 KANSL3 CD44 COL14A1 ALK	3.84e-04	196	110	6	3070_UP
Drug	Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A	ANK3 TIAM1 MUC6 ALK EPB41L1 CDON	3.84e-04	196	110	6	2735_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	KLF12 SPTBN1 ZMYND8 NEK9 NFRKB MUC4	3.84e-04	196	110	6	4685_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	ATN1 ZMYND8 NUP214 KANSL3 TIAM1 EPB41L1	3.84e-04	196	110	6	4200_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	SPTBN1 SRCAP MFAP3L YEATS2 TIAM1 CDH1	3.84e-04	196	110	6	4540_DN
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; MCF7; HT_HG-U133A	ATN1 ZMYND8 WNK1 NEK9 RAPGEF2 HCFC1	3.84e-04	196	110	6	4714_UP
Drug	genistein; Down 200; 10uM; PC3; HT_HG-U133A	SPTBN1 ZMYND8 NEK9 NRXN3 CDH1 ALK	3.95e-04	197	110	6	4459_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	KIF13B NEK9 MFAP3L MUC5AC ALK HCFC1	3.95e-04	197	110	6	1528_UP
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; HL60; HT_HG-U133A	KLF12 ANK3 MFAP3L BMPR2 ALK CDON	3.95e-04	197	110	6	3117_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	ANK3 SPTBN1 KANSL3 TIAM1 MAP3K13 CDH1	3.95e-04	197	110	6	4233_DN
Drug	Mesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A	KIF13B ZMYND8 CPD SRCAP HCFC1 CDON	3.95e-04	197	110	6	7241_DN
Drug	Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A	SPTBN1 NUP214 SRCAP NFRKB MAP3K13 CDH1	3.95e-04	197	110	6	4587_UP
Drug	0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A	KLF12 CPD SRCAP AP3B1 BMPR2 CDH1	3.95e-04	197	110	6	7069_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A	KIF13B NUP214 SRCAP LAMP3 TAF4B MUC6	3.95e-04	197	110	6	3413_UP
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	AFF2 ZMYND8 KDM6B AP3B1 NRXN3 TIAM1	3.95e-04	197	110	6	6867_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	KIF13B SPTBN1 KDM6B SRCAP MFAP3L EPB41L1	3.95e-04	197	110	6	3456_DN
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	ZMYND8 KDM6B MFAP3L NRXN3 TIAM1 HCFC1	3.95e-04	197	110	6	5939_DN
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC3A MUC4 MUC5AC MUC6	1.55e-07	64	111	6	DOID:4947 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC MUC6	5.15e-07	5	111	3	DOID:3030 (is_marker_for)
Disease	Adenoid Cystic Carcinoma	KRT5 KDM6B SRCAP CDH1 MAML3 SON	2.21e-06	100	111	6	C0010606
Disease	Granuloma, Plasma Cell	RANBP2 ALK	1.40e-05	2	111	2	C0018199
Disease	acute graft vs. host disease, donor genotype effect measurement	EYS TMEM131 SDK1	2.28e-05	15	111	3	EFO_0004599, EFO_0007892
Disease	Salivary Gland Neoplasms	KRT5 SPEN CDH1 SON	2.99e-05	47	111	4	C0036095
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	4.20e-05	3	111	2	DOID:9368 (is_marker_for)
Disease	severe cutaneous adverse reaction, response to carbamazepine	MUC22 ALK	8.37e-05	4	111	2	EFO_0006346, EFO_0008484
Disease	invasive lobular carcinoma (is_implicated_in)	CD44 CDH1	8.37e-05	4	111	2	DOID:3457 (is_implicated_in)
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC3A MUC4 MUC5AC	8.39e-05	61	111	4	DOID:3587 (is_marker_for)
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	9.90e-05	24	111	3	DOID:12894 (is_marker_for)
Disease	psychosis predisposition measurement	SFSWAP CCDC141 CD44	1.26e-04	26	111	3	EFO_0008337
Disease	Tinnitus	SPTBN1 CADM2 TMEM131 SDK1 KCNH5	1.36e-04	130	111	5	HP_0000360
Disease	congenital heart disease (implicated_via_orthology)	HCFC2 HCFC1 SON MYBPC1	1.36e-04	69	111	4	DOID:1682 (implicated_via_orthology)
Disease	Inflammatory Myofibroblastic Tumor	RANBP2 ALK	2.08e-04	6	111	2	C0334121
Disease	wellbeing measurement	PCLO MBNL1 ZMYND8 MUC19 CADM2 STAU1 BPTF PTPRQ SDK1 MAML3	2.90e-04	692	111	10	EFO_0007869
Disease	drug use measurement, quality of life during menstruation measurement	SDK1 KCNH5	2.91e-04	7	111	2	EFO_0007010, EFO_0009366
Disease	Headache, fasting blood glucose measurement	GATAD2A AP3B1	2.91e-04	7	111	2	EFO_0004465, HP_0002315
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	2.91e-04	7	111	2	DOID:0050625 (is_marker_for)
Disease	smoking status measurement, Crohn's disease	MUC22 CDH1	2.91e-04	7	111	2	EFO_0000384, EFO_0006527
Disease	common bile duct neoplasm (is_marker_for)	MUC4 MUC5AC	3.87e-04	8	111	2	DOID:4608 (is_marker_for)
Disease	visceral adipose tissue measurement	POM121C WNK1 CADM2 YEATS2 BPTF NRXN3 COL14A1 MAML3	4.80e-04	481	111	8	EFO_0004765
Disease	heart rate response to exercise	MUC3B CCDC141 MUC3A	5.73e-04	43	111	3	EFO_0009184
Disease	pancreatic cancer (is_marker_for)	MUC16 MUC4 MUC5AC MUC6	5.85e-04	101	111	4	DOID:1793 (is_marker_for)
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	6.19e-04	10	111	2	DOID:10140 (is_marker_for)
Disease	otitis media (is_marker_for)	MUC5B MUC4	6.19e-04	10	111	2	DOID:10754 (is_marker_for)
Disease	Malignant neoplasm of salivary gland	KRT5 CDH1 SON	6.55e-04	45	111	3	C0220636
Disease	facial width measurement	SFSWAP PCLO FOXK1 CDON	6.77e-04	105	111	4	EFO_0007855
Disease	pulmonary fibrosis	MUC5B MUC5AC	7.54e-04	11	111	2	EFO_0009448
Disease	Amyotrophic Lateral Sclerosis, Familial	TIAM1 CD68 OTOG	7.92e-04	48	111	3	C4551993
Disease	Amyotrophic Lateral Sclerosis, Sporadic	TIAM1 CD68 OTOG	7.92e-04	48	111	3	C1862941
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	TIAM1 CD68 OTOG	8.93e-04	50	111	3	C1862939
Disease	brain disease (is_implicated_in)	RANBP2 NUP214	9.03e-04	12	111	2	DOID:936 (is_implicated_in)
Disease	plasma beta-amyloid 1-42 measurement	ANK3 KRT86	1.06e-03	13	111	2	EFO_0005660
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	1.24e-03	14	111	2	DOID:10808 (implicated_via_orthology)
Disease	urinary bladder cancer (biomarker_via_orthology)	KRT5 CDH1	1.24e-03	14	111	2	DOID:11054 (biomarker_via_orthology)
Disease	triglycerides in LDL measurement	BPTF HAVCR1 LPA	1.24e-03	56	111	3	EFO_0022320
Disease	asthma (is_marker_for)	MUC5B HAVCR1 BMPR2 MUC5AC	1.33e-03	126	111	4	DOID:2841 (is_marker_for)
Disease	smoking cessation	ANK3 CSMD3 CCDC141 CADM2 NRXN3 MAML3	1.47e-03	325	111	6	EFO_0004319
Disease	triglycerides in small VLDL measurement	BPTF HAVCR1 LPA	1.59e-03	61	111	3	EFO_0022145
Disease	Schizoaffective disorder-bipolar type	PCLO NRXN3	1.63e-03	16	111	2	EFO_0009965
Disease	Cannabis use	CADM2 SDK1	1.63e-03	16	111	2	EFO_0007585
Disease	heart rate	KLF12 CCDC141 C6orf132 FOXK1 DCP1A	1.64e-03	225	111	5	EFO_0004326
Disease	phospholipids in large VLDL measurement	BPTF HAVCR1 LPA	1.67e-03	62	111	3	EFO_0022169
Disease	triglycerides in medium LDL measurement	BPTF HAVCR1 LPA	1.67e-03	62	111	3	EFO_0022322
Disease	Holoprosencephaly	PPP1R12A CDON	1.84e-03	17	111	2	C0079541
Disease	alcoholic liver cirrhosis	GATAD2A TAF4B	1.84e-03	17	111	2	EFO_1000802
Disease	otitis media (biomarker_via_orthology)	MUC4 MUC5AC	1.84e-03	17	111	2	DOID:10754 (biomarker_via_orthology)
Disease	triglycerides in small LDL measurement	BPTF HAVCR1 LPA	1.91e-03	65	111	3	EFO_0022323
Disease	C-reactive protein measurement	ANK3 MBNL1 MFSD4B MSL2 YEATS2 BPTF BMPR2 ZNF608 LPA TAF4B MAML3 ARMH4	1.96e-03	1206	111	12	EFO_0004458
Disease	age at initiation of smoking	CADM2 SDK1 MAML3	2.00e-03	66	111	3	EFO_0021784
Disease	eosinophil percentage of leukocytes	KLF12 ZMYND8 NR4A3 KDM6B WNK1 KANSL3 BPTF TMEM131 MUC5AC	2.06e-03	746	111	9	EFO_0007991
Disease	neuroticism measurement, wellbeing measurement, depressive symptom measurement	SDK1 MAML3	2.30e-03	19	111	2	EFO_0007006, EFO_0007660, EFO_0007869
Disease	Mammary Neoplasms, Experimental	KRT5 CSN3 CD44 CDH1	2.84e-03	155	111	4	C0024668
Disease	non-melanoma skin carcinoma	KRT5 MUC22 EPB41 EPB41L1 ARMH4	3.33e-03	265	111	5	EFO_0009260

Protein segments in the cluster

Peptide	Gene	Start	Entry
TTTSATTVATEPTSQ	ESYT3	646	A0FGR9
TAQTITSETPSSTTT	EPB41	786	P11171
TSETPSSTTTTQITK	EPB41	791	P11171
ASTPADVTVSSVTAV	CSMD3	371	Q7Z407
TTLFSTSVDTVTPST	ADGRG4	1126	Q8IZF6
TSVDTVTPSTHTLVC	ADGRG4	1131	Q8IZF6
IATATVTATAIVTTT	AFF2	991	P51816
VTATAIVTTTVTATA	AFF2	996	P51816
ATTISTTVVPLSFEV	ARMH4	521	Q86TY3
SATLSTVIATVASSP	ATN1	611	P54259
TRTSSESIISVPASS	ABLIM2	276	Q6H8Q1
TVVTTTVTDSLTTTG	BPTF	1781	Q12830
TATTTAVSSVLLAPS	DCP1A	491	Q9NPI6
LSTSSSVISVSTPAF	AP3B1	851	O00203
VSTTATTPTVTSSKA	MUC5B	2496	Q9HC84
PETVHTSTVLTTTAT	MUC5B	2571	Q9HC84
THTPTVLTTTTTTVA	MUC5B	2656	Q9HC84
LTSTATTPTVISSRA	MUC5B	3196	Q9HC84
RSTATTPTATSVTAI	MUC5B	3226	Q9HC84
PETVHTSTVLTTTTT	MUC5B	3271	Q9HC84
STTATVTVPTGSTAT	MUC5B	3726	Q9HC84
PTVLTTTTTTVATGS	MUC5B	3916	Q9HC84
LTTTATTPAATSSTV	MUC5B	3976	Q9HC84
LTSTATKSTATSVTP	MUC5B	4311	Q9HC84
VSTTATTPTVTSSKA	MUC5B	4481	Q9HC84
PETVHTSTVLTATAT	MUC5B	4556	Q9HC84
SSLPTFSVSTVSSSV	MUC5B	4911	Q9HC84
ATSEVEVSSTSETTP	RANBP2	2491	P49792
LSVAETQVTPSSVTT	KIAA1549	541	Q9HCM3
TQVTPSSVTTAFFSV	KIAA1549	546	Q9HCM3
FTVTPTVTESTGTTS	CD68	36	P34810
TTTTTTPTITTSQAA	MFRP	111	Q9BY79
STPTSVASVVTSAES	GATAD2A	326	Q86YP4
VSSATNTSTRPIITV	HCFC1	621	P51610
TTSPSTTLVSEETNT	MUC16	406	Q8WXI7
ATSIREPSTTILTTE	MUC16	1011	Q8WXI7
TSPIVLTASFTETST	MUC16	2326	Q8WXI7
TTAETQTLTFTPSET	MUC16	3106	Q8WXI7
VTETSTVLSEVPTTT	MUC16	5796	Q8WXI7
TVLSEVPTTTTTEVS	MUC16	5801	Q8WXI7
VPTTTTTEVSRTEVI	MUC16	5806	Q8WXI7
STETITRISTPLTTT	MUC16	8766	Q8WXI7
STVLSSVPTGATTEV	MUC16	9306	Q8WXI7
SLVTSSRAVTSTTIP	MUC16	10936	Q8WXI7
LVASSRAVTSTTLPT	MUC16	10991	Q8WXI7
VTSSRAVTSTTIPTL	MUC16	11156	Q8WXI7
AVTSTTIPTLTISSD	MUC16	11161	Q8WXI7
TISSDEPETTTSLVT	MUC16	11171	Q8WXI7
VTSPEAESSSAISTT	MUC16	11296	Q8WXI7
TSSATDTSTAIPTLT	MUC16	11636	Q8WXI7
TSPRTEASSAVLTTI	MUC16	11721	Q8WXI7
TSTSTLTLTVSPAVS	MUC16	11886	Q8WXI7
LNTLTPVTTSTVLSS	MUC4	341	Q99102
DTTPLLVTDASSVST	MUC4	3581	Q99102
TRPTATETTQTRTTT	MUC6	1381	Q6W4X9
TETTQTRTTTEYTTP	MUC6	1386	Q6W4X9
IATTPSITTETISTT	EPB41L1	741	Q9H4G0
TAEPSTDVTSTELTS	MFAP3L	356	O75121
TVIPETSVSSTVSST	HCFC2	506	Q9Y5Z7
TVALSATPTTSVIRS	EYS	1416	Q5T1H1
TVRQVPVSTTVVSTS	NFRKB	1161	Q6P4R8
SSTVTEAPIAVVTSR	NEK9	331	Q8TD19
STVSTATSLPSVAST	MAML3	386	Q96JK9
TTGTTDTVPITTTSF	MGAM2	1851	Q2M2H8
TTPFATSTISVTTST	MGAM2	1981	Q2M2H8
TSTISVTTSTTVPDT	MGAM2	1986	Q2M2H8
SVTPSLTSTADATIS	MGAM2	2101	Q2M2H8
ETIVASTTVSGTTTT	MUC22	126	E2RYF6
GTTTTFTIASTTVPE	MUC22	136	E2RYF6
QTTIVSISGSEITTT	MUC22	306	E2RYF6
TITPSTAGSETTTVS	MUC22	436	E2RYF6
ITVSAEGSETTTVTT	MUC22	1206	E2RYF6
TVSETTTVSTIGSEA	MUC22	1401	E2RYF6
VTIPRSTSDTDLVTS	HECW1	61	Q76N89
LLPSTTSSSVSVISI	KIAA2026	1406	Q5HYC2
ECPSAVSISVVSSST	KRT3	516	P12035
SAITPSVSRTSFTSV	KRT5	21	P13647
CASTTAPVVSTRVSS	KRT86	441	O43790
APAVAVTTTTTTTTT	KDM6B	746	O15054
SITGTSVVTVSQITP	KCNH5	746	Q8NCM2
TPSLTSSVSSVCTTD	PCLO	2181	Q9Y6V0
SSSPITTLDSITTVY	PCLO	2196	Q9Y6V0
TSSIVTPVSLATETV	PCLO	2781	Q9Y6V0
TAASIPAITTSSSET	MUC19	1671	Q7Z5P9
TTISSPEVSTISEVS	MUC19	6211	Q7Z5P9
VTVTPSSVSATDTTF	MUC3A	201	Q02505
TAVTSTSPITSSITS	MUC3A	251	Q02505
TSPITSSITSTNTVT	MUC3A	256	Q02505
TILSSTPVLSTETIT	MUC3A	291	Q02505
AESTLAPTTTTSFTT	MUC3A	566	Q02505
ASTYTTAITSVPTTL	MUC3A	786	Q02505
TTTLTPTTDISTVSL	MUC3A	986	Q02505
TLLTTITRSTPTSET	MUC3A	1071	Q02505
PTSIVSDSTTEITYS	MUC3A	1091	Q02505
SLRPTITSTDSTLTS	MUC3A	1261	Q02505
STATFLETTTLTPTT	MUC3A	1356	Q02505
LETTTLTPTTDFSTE	MUC3A	1361	Q02505
SSPTSTVTESTTEIT	MUC3A	1466	Q02505
SSSLLTTVTATVPTT	MUC3A	1876	Q02505
TTVTATVPTTNLVTT	MUC3A	1881	Q02505
TPSFTSLITITEITS	MUC3A	2056	Q02505
TPNFTSSITTTETTS	MUC3A	2141	Q02505
TTAAATTATTAAPTT	MUCL1	46	Q96DR8
TTATTAAPTTATTAA	MUCL1	51	Q96DR8
VSETSRTTTTSLSPE	NRXN3	1466	Q9Y4C0
SIVRSTTITLTPSAE	MEGF8	701	Q7Z7M0
TTITLTPSAETDVSL	MEGF8	706	Q7Z7M0
TSSTPIASSTTSIVA	NUP214	1611	P35658
TTSPITYTLVTTQAT	LAMP3	96	Q9UQV4
STISARTTSIISAPT	MUC5AC	3421	P98088
RTTSIISAPTTSTTS	MUC5AC	3426	P98088
TAISTIVVAASTTVT	HUWE1	3521	Q7Z6Z7
IVVAASTTVTTPTTA	HUWE1	3526	Q7Z6Z7
TSTSVINVTGSPVTT	MSL2	541	Q9HCI7
SLPSSTELTTTAVST	GORASP1	326	Q9BQQ3
SIIETSRSSLTEPTA	MFSD4B	466	Q5TF39
VATTPSLVTSSAATT	POU2F1	461	P14859
SLVTSSAATTLTVSP	POU2F1	466	P14859
ISSISTTYTSPVTRI	PTPRQ	76	Q9UMZ3
ALPTTTTVTTFSQSL	POM121C	866	A8CG34
TTTTVTTFSQSLPTA	POM121B	476	A6NF01
HSPVTTTVLTSVSED	MAP3K13	61	O43283
IASTATTLPTTTSQL	C6orf132	691	Q5T0Z8
ESTVATAAASTTEVP	GSN-AS1	126	Q9NRJ2
RPTISTASETSVYVT	BOC	611	Q9BWV1
SPSVALSTTTVSSVA	CCDC141	6	Q6ZP82
STSTIQATPSSTTEE	CD44	381	P16070
PTSTVSVTEDSSTSE	CRTAM	241	O95727
TVVEPASSTSVVLSS	COL12A1	676	Q99715
ATTIVPTTSVTSVFQ	COL14A1	721	Q05707
RPTISTASETSVYVT	CDON	726	Q4KMG0
PETSVTSLSTNTTTT	BMPR2	601	Q13873
VIPDTTEAVSTASTV	CPD	466	O75976
IPSLTTATVTTTVAI	CADM2	326	Q8N3J6
TATVTTTVAITTSPT	CADM2	331	Q8N3J6
TTVAITTSPTTSATT	CADM2	336	Q8N3J6
VAATATTTPATATTA	FOXK1	676	P85037
TTSSVTSSIITVPVY	ANK3	1811	Q12955
PVTESSVLATSTAVS	LPA	1246	P08519
TPATVSAATTSATSV	MBNL1	346	Q9NR56
TTGTSTIVRTIPVAT	KANSL3	796	Q9P2N6
SRLASSPTVITSVSS	KLF12	121	Q9Y4X4
IPVTSSVTLSSSDLS	KRTAP24-1	26	Q3LI83
FSESIITSTPETTTV	CSN3	161	P07498
SVSAPSLITDSVISV	CEP295	616	Q9C0D2
TATAATTSTEPITVA	DYNAP	191	Q8N1N2
TATTSTSSTVTVTAP	ZMYND8	776	Q9ULU4
TQSPSTSTITLVTST	ZMYND8	876	Q9ULU4
TSTITLVTSTQSSPL	ZMYND8	881	Q9ULU4
APTSVTVRTASETSL	SDK1	1176	Q7Z5N4
PFEVSLTTSTATVTV	CDH1	461	P12830
VIPSSNVSITTSTIR	FAM8A1	356	Q9UBU6
ATTTEANTSTTCVPI	OTOG	2041	Q6ZRI0
LVVSSEASTLSTTPA	MUC17	286	Q685J3
VITSTEASSSPTTAE	MUC17	306	Q685J3
ITPVDTSTLVTTSTE	MUC17	356	Q685J3
SEASTLSTTPVDTST	MUC17	526	Q685J3
VDTSTPVTTSSEASS	MUC17	536	Q685J3
PVSTRLVVSSEASTT	MUC17	576	Q685J3
LVVSSEASTTSTTPA	MUC17	581	Q685J3
VDSNSPVTTSTEVSS	MUC17	831	Q685J3
PVSTTLVATSAISTL	MUC17	871	Q685J3
LVATSAISTLSTTPV	MUC17	876	Q685J3
VPVSTRLVVSSEAST	MUC17	1106	Q685J3
RLVVSSEASTLSTTP	MUC17	1111	Q685J3
SEASTLSTTPVDTSI	MUC17	1116	Q685J3
VDTSIPVTTSTEASS	MUC17	1126	Q685J3
STTPVDSKTQVATST	MUC17	1181	Q685J3
STTLVTSPEASTLLT	MUC17	1286	Q685J3
LTSIPVSTTTVASSE	MUC17	1516	Q685J3
TVRTTPVASSAISTL	MUC17	1696	Q685J3
VTTSTEARSSPTTSE	MUC17	1721	Q685J3
VSTTPVLSSEASTLS	MUC17	1756	Q685J3
STALTSIPVSTTTVA	MUC17	1866	Q685J3
SIPVSTTTVASSETN	MUC17	1871	Q685J3
IPVSTTTVASSEINT	MUC17	1931	Q685J3
LVVSSEASTLSTTPV	MUC17	1996	Q685J3
TVVASSAISTLSTTP	MUC17	2171	Q685J3
SAISTLSTTPVDTST	MUC17	2176	Q685J3
VTTSTEATSSPTTAE	MUC17	2251	Q685J3
STPSEVSTSLTSILV	MUC17	2626	Q685J3
STLSTTPVDTRTLVT	MUC17	2651	Q685J3
TPVDTRTLVTTSTGT	MUC17	2656	Q685J3
VSTTAVDTSIPVTTS	MUC17	2771	Q685J3
VDTSIPVTTSTEASS	MUC17	2776	Q685J3
VTTSTKASSSPTTAE	MUC17	2841	Q685J3
VSTTPVASSEASTLS	MUC17	2876	Q685J3
TTVASSETSTLSTTP	MUC17	3291	Q685J3
PVVSSEASTLSTTPV	MUC17	3351	Q685J3
DTSTPVTTSTEASLS	MUC17	3366	Q685J3
VTTSTEASLSPTTAE	MUC17	3371	Q685J3
VSTTPVVSSEVNTLS	MUC17	3406	Q685J3
TTPVDSNTLVTTSTE	MUC17	3421	Q685J3
STTPVASSEASTLST	MUC17	3466	Q685J3
TTPVASSEASTLSTT	MUC17	3526	Q685J3
DTSTPVITSTQVSSS	MUC17	3661	Q685J3
TSTPVTTSTEAISSS	MUC17	3721	Q685J3
DTASTPTIPVATTIS	MUC17	3911	Q685J3
ATTISVSVITEGSTP	MUC17	3921	Q685J3
ATTGAVSTPVITSTE	MUC17	3956	Q685J3
TTSASSTTVNPEAVT	MUC17	4076	Q685J3
VTTTQVTFTSSYTPT	MUC3B	146	Q9H195
VTVTPSSSVSATDTT	MUC3B	201	Q9H195
STSPITSTITSTNTV	MUC3B	256	Q9H195
TENTPISSFSTSIVV	MUC3B	471	Q9H195
SPTSSSLTTALTEIT	MUC3B	656	Q9H195
TSVATTQTPTTLTTC	MUC3B	836	Q9H195
EITATATTSLPSIST	NR4A3	46	Q92570
VIVAPEVDTSSSSVS	KIF13B	901	Q9NQT8
TCTTTVTTSPVVTTT	TAF4B	356	Q92750
VTTSPVVTTTVSSSQ	TAF4B	361	Q92750
TATTVVAAASSTSIP	SYVN1	546	Q86TM6
TTTTTSALAPVAAII	SFSWAP	436	Q12872
TSTITITPVTTSSAR	FILIP1	1126	Q7Z7B0
SETSRTTTTSLSPEL	NRXN3	461	Q9HDB5
TTVPTVTTVRTSTTV	HAVCR1	136	Q96D42
ISDSTSTPATTRVTT	SI	41	P14410
TTSTTTATATTTAVP	SRCAP	1146	Q6ZRS2
VPTLSIVASTASSVA	SUSD6	116	Q92537
TSTTTQDTTPFKITT	PRG4	961	Q92954
AQTLPTSVVTITSES	SPTBN1	2326	Q01082
LSTTDVPASESATVT	ALK	521	Q9UM73
ATATVISSPSTEELS	RAPGEF2	1216	Q9Y4G8
SSVTPSVDSSIVLTA	TIAM1	106	Q13009
STSVTTAIAEPVSAA	SPEN	2551	Q96T58
ITSTSAAAESITPTV	STAU1	61	O95793
TTTATSVAQTVSTPT	TCERG1	286	O14776
SSEETITLVSISATT	TMEM131	136	Q92545
TVHLTSVETTPESTT	TTLL6	631	Q8N841
SVETTPESTTQLSIS	TTLL6	636	Q8N841
AIPTATFTTTTTGTI	ZNF608	751	Q9ULD9
LQVPTSTSEIVVSST	WNK1	1431	Q9H4A3
SSTSTPTLAETVVVS	WNK1	1511	Q9H4A3
ESSVLSSSSPESTLV	WNK1	1891	Q9H4A3
TVLESSTVTVLESST	SON	1366	P18583
TTITTAAATSVTVPG	ZBTB22	156	O15209
ISVSVSETSEPLTSD	KIAA0586	951	Q9BVV6
APVSSSTVSSVTKTS	YEATS2	976	Q9ULM3
PVTVSQTSVVSILTS	ZNF311	651	Q5JNZ3
TETTVFPRSTTTSVR	MUC12	3951	Q9UKN1
ESTTVHSSPVATATT	MUC12	4716	Q9UKN1
PSFTSTIVSTESLET	MUC12	5111	Q9UKN1
PTLLTVDSVTDTTVT	MYBPC1	721	Q00872
PTVVNAAASTTTLTT	PPP1R12A	636	O14974